Gene Symbol | Gene ID | Gene Info |
---|---|---|
Elf5
|
ENSMUSG00000027186.8 | E74-like factor 5 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_103415880_103416031 | Elf5 | 4242 | 0.195368 | 0.37 | 5.9e-03 | Click! |
chr2_103466410_103466561 | Elf5 | 17747 | 0.161377 | 0.20 | 1.4e-01 | Click! |
chr2_103439829_103440014 | Elf5 | 6958 | 0.187085 | -0.19 | 1.6e-01 | Click! |
chr2_103425583_103425734 | Elf5 | 830 | 0.599617 | -0.15 | 2.7e-01 | Click! |
chr2_103424712_103424887 | Elf5 | 29 | 0.975275 | -0.12 | 3.8e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr15_101995547_101995886 | 24.10 |
Gm36026 |
predicted gene, 36026 |
8496 |
0.11 |
chr1_86040103_86040670 | 23.28 |
2810459M11Rik |
RIKEN cDNA 2810459M11 gene |
5477 |
0.12 |
chr1_74409147_74409334 | 22.08 |
Vil1 |
villin 1 |
136 |
0.93 |
chr17_74459061_74459310 | 21.17 |
Nlrc4 |
NLR family, CARD domain containing 4 |
43 |
0.97 |
chr11_119314358_119314530 | 19.54 |
Card14 |
caspase recruitment domain family, member 14 |
343 |
0.82 |
chrX_42067696_42069057 | 18.51 |
Xiap |
X-linked inhibitor of apoptosis |
22 |
0.98 |
chr14_14351950_14353283 | 18.34 |
Il3ra |
interleukin 3 receptor, alpha chain |
2995 |
0.15 |
chr8_40019255_40019574 | 18.27 |
Gm7082 |
predicted gene 7082 |
2700 |
0.41 |
chr17_40873569_40873790 | 18.15 |
9130008F23Rik |
RIKEN cDNA 9130008F23 gene |
6879 |
0.14 |
chr7_75416003_75416186 | 17.56 |
Gm44962 |
predicted gene 44962 |
5041 |
0.21 |
chr17_5798459_5798854 | 16.92 |
3300005D01Rik |
RIKEN cDNA 3300005D01 gene |
1 |
0.97 |
chr18_74768230_74768413 | 16.47 |
Scarna17 |
small Cajal body-specific RNA 17 |
10148 |
0.15 |
chr11_86579032_86579443 | 16.43 |
Mir21a |
microRNA 21a |
4921 |
0.16 |
chr6_137570741_137570922 | 16.41 |
Eps8 |
epidermal growth factor receptor pathway substrate 8 |
72 |
0.98 |
chr5_144296273_144296524 | 16.32 |
Baiap2l1 |
BAI1-associated protein 2-like 1 |
7491 |
0.15 |
chr10_59629113_59629279 | 16.23 |
Mcu |
mitochondrial calcium uniporter |
12504 |
0.19 |
chr2_69135675_69135888 | 16.22 |
Nostrin |
nitric oxide synthase trafficker |
19 |
0.98 |
chr3_30140699_30140860 | 16.04 |
Mecom |
MDS1 and EVI1 complex locus |
356 |
0.89 |
chr2_180276800_180277281 | 15.79 |
Cables2 |
CDK5 and Abl enzyme substrate 2 |
3544 |
0.14 |
chr3_84581929_84583242 | 15.61 |
Arfip1 |
ADP-ribosylation factor interacting protein 1 |
40 |
0.97 |
chr4_143412586_143413277 | 15.43 |
Pramef8 |
PRAME family member 8 |
41 |
0.96 |
chr1_191277526_191278108 | 15.33 |
Gm37168 |
predicted gene, 37168 |
10639 |
0.13 |
chr17_36885232_36885383 | 15.26 |
Trim40 |
tripartite motif-containing 40 |
4226 |
0.09 |
chr2_167492358_167493413 | 15.22 |
Spata2 |
spermatogenesis associated 2 |
2 |
0.76 |
chr5_134549639_134549972 | 14.93 |
Gm42884 |
predicted gene 42884 |
2252 |
0.16 |
chr16_32563013_32563416 | 14.82 |
Gm34680 |
predicted gene, 34680 |
11472 |
0.14 |
chr11_94774856_94775172 | 14.81 |
Tmem92 |
transmembrane protein 92 |
7486 |
0.11 |
chr2_113440692_113441351 | 14.78 |
Fmn1 |
formin 1 |
43 |
0.52 |
chr3_3526060_3526383 | 14.74 |
Hnf4g |
hepatocyte nuclear factor 4, gamma |
18191 |
0.19 |
chr19_55136783_55136974 | 14.67 |
Gpam |
glycerol-3-phosphate acyltransferase, mitochondrial |
9640 |
0.19 |
chr11_112910526_112910687 | 14.63 |
4933434M16Rik |
RIKEN cDNA 4933434M16 gene |
85427 |
0.09 |
chr2_71814136_71814304 | 14.56 |
Itga6 |
integrin alpha 6 |
12542 |
0.17 |
chr6_113668498_113668869 | 14.49 |
Irak2 |
interleukin-1 receptor-associated kinase 2 |
167 |
0.87 |
chr18_74897013_74897365 | 14.33 |
Gm24559 |
predicted gene, 24559 |
9245 |
0.12 |
chr11_108241336_108241590 | 14.32 |
Gm11655 |
predicted gene 11655 |
59613 |
0.12 |
chr13_48958649_48958947 | 14.30 |
Fam120a |
family with sequence similarity 120, member A |
9219 |
0.24 |
chr15_102393639_102394041 | 14.21 |
Sp1 |
trans-acting transcription factor 1 |
12303 |
0.09 |
chr13_74102065_74102235 | 13.82 |
Slc9a3 |
solute carrier family 9 (sodium/hydrogen exchanger), member 3 |
19307 |
0.15 |
chr14_16319766_16320101 | 13.80 |
Gm47798 |
predicted gene, 47798 |
15422 |
0.14 |
chr16_13883471_13883663 | 13.75 |
Pdxdc1 |
pyridoxal-dependent decarboxylase domain containing 1 |
7420 |
0.14 |
chr7_101377706_101378260 | 13.52 |
Arap1 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 |
207 |
0.89 |
chr2_153424682_153425044 | 13.46 |
Gm14472 |
predicted gene 14472 |
11014 |
0.16 |
chr17_87299012_87299237 | 13.45 |
Ttc7 |
tetratricopeptide repeat domain 7 |
6313 |
0.15 |
chr4_58064846_58064997 | 13.32 |
Txndc8 |
thioredoxin domain containing 8 |
55797 |
0.14 |
chr2_132939064_132939367 | 13.32 |
Fermt1 |
fermitin family member 1 |
2748 |
0.22 |
chr10_111074173_111074334 | 13.31 |
Gm48851 |
predicted gene, 48851 |
28618 |
0.14 |
chr4_49558167_49558484 | 13.25 |
Aldob |
aldolase B, fructose-bisphosphate |
8779 |
0.14 |
chr2_102815250_102815593 | 13.14 |
Slc1a2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
54248 |
0.12 |
chr8_79104309_79104478 | 13.14 |
Zfp827 |
zinc finger protein 827 |
13934 |
0.23 |
chr13_3700776_3701101 | 13.12 |
Gm23084 |
predicted gene, 23084 |
52401 |
0.09 |
chr15_82362127_82362278 | 13.09 |
Ndufa6 |
NADH:ubiquinone oxidoreductase subunit A6 |
7880 |
0.07 |
chr5_117123214_117123371 | 13.05 |
Taok3 |
TAO kinase 3 |
3009 |
0.18 |
chr16_96361545_96361779 | 12.92 |
Igsf5 |
immunoglobulin superfamily, member 5 |
6 |
0.63 |
chr14_27667399_27667557 | 12.89 |
Erc2 |
ELKS/RAB6-interacting/CAST family member 2 |
14651 |
0.23 |
chr7_35383128_35383449 | 12.72 |
Rhpn2 |
rhophilin, Rho GTPase binding protein 2 |
723 |
0.58 |
chr7_92688003_92688166 | 12.62 |
Pcf11 |
PCF11 cleavage and polyadenylation factor subunit |
18150 |
0.11 |
chr7_28832087_28832447 | 12.62 |
Ech1 |
enoyl coenzyme A hydratase 1, peroxisomal |
1016 |
0.28 |
chr17_31319267_31319484 | 12.62 |
Slc37a1 |
solute carrier family 37 (glycerol-3-phosphate transporter), member 1 |
199 |
0.92 |
chr3_96875239_96875430 | 12.60 |
Gpr89 |
G protein-coupled receptor 89 |
874 |
0.48 |
chr4_133598648_133599053 | 12.59 |
Sfn |
stratifin |
3318 |
0.13 |
chr7_126746842_126747128 | 12.55 |
Gm44855 |
predicted gene 44855 |
2570 |
0.09 |
chr5_45925979_45926422 | 12.48 |
4930405L22Rik |
RIKEN cDNA 4930405L22 gene |
6209 |
0.25 |
chr1_162871120_162871286 | 12.44 |
Fmo1 |
flavin containing monooxygenase 1 |
4593 |
0.2 |
chr18_20057758_20058119 | 12.41 |
Dsc2 |
desmocollin 2 |
1540 |
0.47 |
chr3_21986227_21986389 | 12.36 |
Gm43674 |
predicted gene 43674 |
12160 |
0.21 |
chr19_53208881_53209116 | 12.29 |
Add3 |
adducin 3 (gamma) |
10952 |
0.16 |
chr6_108442337_108443036 | 12.23 |
Itpr1 |
inositol 1,4,5-trisphosphate receptor 1 |
16017 |
0.18 |
chr4_149445330_149446172 | 12.23 |
Rbp7 |
retinol binding protein 7, cellular |
7673 |
0.11 |
chr12_31437942_31438104 | 12.21 |
Slc26a3 |
solute carrier family 26, member 3 |
194 |
0.93 |
chr6_40635573_40635914 | 12.18 |
Mgam |
maltase-glucoamylase |
6912 |
0.16 |
chr2_133511465_133511774 | 12.10 |
Bmp2 |
bone morphogenetic protein 2 |
40540 |
0.14 |
chr7_142068509_142068813 | 12.06 |
Mob2 |
MOB kinase activator 2 |
7596 |
0.09 |
chr4_59553480_59553866 | 11.98 |
Ptbp3 |
polypyrimidine tract binding protein 3 |
4309 |
0.17 |
chr19_29675587_29675738 | 11.96 |
Mlana |
melan-A |
22162 |
0.17 |
chrX_13245124_13245313 | 11.96 |
2010308F09Rik |
RIKEN cDNA 2010308F09 gene |
2518 |
0.17 |
chr11_76483220_76483432 | 11.90 |
Abr |
active BCR-related gene |
10603 |
0.2 |
chr9_45103695_45103876 | 11.87 |
Jaml |
junction adhesion molecule like |
75 |
0.94 |
chr3_138419364_138419542 | 11.85 |
Adh4 |
alcohol dehydrogenase 4 (class II), pi polypeptide |
3958 |
0.16 |
chrX_48234608_48234766 | 11.84 |
Gm24038 |
predicted gene, 24038 |
4401 |
0.18 |
chr9_120826263_120826452 | 11.75 |
Gm39459 |
predicted gene, 39459 |
8006 |
0.11 |
chr5_144086615_144086766 | 11.67 |
Lmtk2 |
lemur tyrosine kinase 2 |
13746 |
0.13 |
chr1_78507261_78507443 | 11.65 |
Mogat1 |
monoacylglycerol O-acyltransferase 1 |
3639 |
0.18 |
chr17_84181102_84182153 | 11.61 |
Gm36279 |
predicted gene, 36279 |
4129 |
0.18 |
chr5_134967591_134967836 | 11.59 |
Cldn3 |
claudin 3 |
18501 |
0.07 |
chr14_57084344_57084685 | 11.59 |
Gjb2 |
gap junction protein, beta 2 |
20188 |
0.13 |
chr2_129129245_129130482 | 11.58 |
Chchd5 |
coiled-coil-helix-coiled-coil-helix domain containing 5 |
13 |
0.96 |
chr2_93112449_93112610 | 11.58 |
Gm13802 |
predicted gene 13802 |
14285 |
0.21 |
chr11_79157732_79158072 | 11.56 |
Ksr1 |
kinase suppressor of ras 1 |
11495 |
0.2 |
chr4_10967879_10968217 | 11.55 |
Rps11-ps3 |
ribosomal protein S11, pseudogene 3 |
21440 |
0.16 |
chr1_83146669_83146862 | 11.52 |
Gm29519 |
predicted gene 29519 |
11219 |
0.12 |
chr11_99458982_99459191 | 11.51 |
Krt20 |
keratin 20 |
20936 |
0.08 |
chr5_74702855_74703181 | 11.49 |
Gm15984 |
predicted gene 15984 |
2 |
0.59 |
chr7_128033009_128033164 | 11.49 |
Gm9299 |
predicted gene 9299 |
9304 |
0.07 |
chr18_69152096_69152441 | 11.44 |
Gm23536 |
predicted gene, 23536 |
21852 |
0.17 |
chr9_45202427_45202624 | 11.42 |
Tmprss4 |
transmembrane protease, serine 4 |
1461 |
0.25 |
chr9_11436888_11437050 | 11.40 |
Gm18160 |
predicted gene, 18160 |
90610 |
0.08 |
chr3_104227644_104227795 | 11.36 |
Magi3 |
membrane associated guanylate kinase, WW and PDZ domain containing 3 |
7345 |
0.13 |
chr7_78864420_78864745 | 11.34 |
Gm44730 |
predicted gene 44730 |
6140 |
0.12 |
chr15_82361448_82361723 | 11.32 |
Ndufa6 |
NADH:ubiquinone oxidoreductase subunit A6 |
7263 |
0.07 |
chr6_16855086_16855250 | 11.30 |
Tfec |
transcription factor EC |
9172 |
0.26 |
chr10_118978302_118978641 | 11.26 |
Gm47461 |
predicted gene, 47461 |
43199 |
0.11 |
chr7_18884324_18884563 | 11.19 |
Pglyrp1 |
peptidoglycan recognition protein 1 |
237 |
0.86 |
chr19_47508609_47509300 | 11.18 |
Stn1 |
STN1, CST complex subunit |
181 |
0.94 |
chr16_45644530_45644719 | 11.18 |
Gm49585 |
predicted gene, 49585 |
2267 |
0.23 |
chr11_78981943_78982094 | 11.16 |
Lgals9 |
lectin, galactose binding, soluble 9 |
2813 |
0.25 |
chr14_44912924_44913077 | 11.14 |
Gm18524 |
predicted gene, 18524 |
7252 |
0.1 |
chr2_128710694_128710995 | 11.14 |
Mertk |
MER proto-oncogene tyrosine kinase |
11888 |
0.15 |
chr9_42196561_42196949 | 11.13 |
4930546K05Rik |
RIKEN cDNA 4930546K05 gene |
12458 |
0.19 |
chr14_57386735_57387214 | 11.11 |
Gm29717 |
predicted gene, 29717 |
1724 |
0.28 |
chr10_37325575_37325788 | 11.10 |
Gm26535 |
predicted gene, 26535 |
11805 |
0.26 |
chr3_28232944_28233216 | 11.10 |
Gm37098 |
predicted gene, 37098 |
12443 |
0.2 |
chr16_78260881_78261045 | 11.08 |
E330011O21Rik |
RIKEN cDNA E330011O21 gene |
4989 |
0.18 |
chr6_114930071_114930644 | 11.04 |
Vgll4 |
vestigial like family member 4 |
8536 |
0.23 |
chr4_135919068_135919228 | 11.04 |
Fuca1 |
fucosidase, alpha-L- 1, tissue |
1587 |
0.22 |
chr3_88593979_88594208 | 11.02 |
Arhgef2 |
rho/rac guanine nucleotide exchange factor (GEF) 2 |
11873 |
0.08 |
chr4_116660961_116661143 | 11.01 |
Akr1a1 |
aldo-keto reductase family 1, member A1 (aldehyde reductase) |
9372 |
0.1 |
chr11_79006516_79006693 | 11.01 |
Ksr1 |
kinase suppressor of ras 1 |
13806 |
0.16 |
chr19_3632108_3632278 | 11.01 |
Lrp5 |
low density lipoprotein receptor-related protein 5 |
16401 |
0.14 |
chr6_86775025_86775336 | 10.98 |
Anxa4 |
annexin A4 |
9270 |
0.14 |
chr2_15188409_15188561 | 10.98 |
Gm13313 |
predicted gene 13313 |
60885 |
0.12 |
chr1_86479174_86479713 | 10.97 |
Rpl30-ps6 |
ribosomal protein L30, pseudogene 6 |
5784 |
0.15 |
chr10_20186593_20186744 | 10.97 |
Map7 |
microtubule-associated protein 7 |
14661 |
0.15 |
chr15_94559386_94559563 | 10.94 |
Irak4 |
interleukin-1 receptor-associated kinase 4 |
15802 |
0.17 |
chr5_100632573_100632784 | 10.93 |
Coq2 |
coenzyme Q2 4-hydroxybenzoate polyprenyltransferase |
31741 |
0.11 |
chr9_69442848_69443037 | 10.87 |
Gm18587 |
predicted gene, 18587 |
2021 |
0.2 |
chr2_157245722_157245873 | 10.81 |
Mroh8 |
maestro heat-like repeat family member 8 |
12251 |
0.16 |
chr7_80781882_80782033 | 10.79 |
Iqgap1 |
IQ motif containing GTPase activating protein 1 |
21306 |
0.15 |
chr19_55137161_55137328 | 10.77 |
Gpam |
glycerol-3-phosphate acyltransferase, mitochondrial |
10006 |
0.19 |
chr18_79026702_79027338 | 10.76 |
Setbp1 |
SET binding protein 1 |
82371 |
0.11 |
chr10_24133270_24133421 | 10.75 |
Gm40614 |
predicted gene, 40614 |
865 |
0.45 |
chr9_45103311_45103478 | 10.72 |
Jaml |
junction adhesion molecule like |
420 |
0.68 |
chr18_65072061_65072361 | 10.68 |
Nedd4l |
neural precursor cell expressed, developmentally down-regulated gene 4-like |
3821 |
0.29 |
chr2_157614045_157614349 | 10.67 |
Platr27 |
pluripotency associated transcript 27 |
16877 |
0.14 |
chr12_51915016_51915167 | 10.66 |
Heatr5a |
HEAT repeat containing 5A |
3635 |
0.26 |
chr11_35955648_35955869 | 10.65 |
Wwc1 |
WW, C2 and coiled-coil domain containing 1 |
24769 |
0.2 |
chr2_153259593_153259812 | 10.63 |
Pofut1 |
protein O-fucosyltransferase 1 |
2130 |
0.24 |
chr17_34355051_34355202 | 10.62 |
Btnl2 |
butyrophilin-like 2 |
304 |
0.77 |
chr8_65129513_65129677 | 10.61 |
Smim31 |
small integral membrane protein 31 |
32 |
0.96 |
chr17_84156748_84156901 | 10.59 |
Gm19696 |
predicted gene, 19696 |
384 |
0.84 |
chr15_31569703_31570012 | 10.58 |
Cmbl |
carboxymethylenebutenolidase-like (Pseudomonas) |
1059 |
0.42 |
chr8_104061451_104061621 | 10.57 |
Gm8748 |
predicted gene 8748 |
9613 |
0.18 |
chr16_91056426_91056805 | 10.54 |
4931406G06Rik |
RIKEN cDNA 4931406G06 gene |
11959 |
0.1 |
chr5_117133755_117134546 | 10.54 |
Taok3 |
TAO kinase 3 |
509 |
0.72 |
chr17_26116840_26117159 | 10.53 |
Tmem8 |
transmembrane protein 8 |
368 |
0.71 |
chr14_47515182_47515384 | 10.52 |
Gm35166 |
predicted gene, 35166 |
7096 |
0.12 |
chr11_56064768_56065096 | 10.48 |
Nmur2 |
neuromedin U receptor 2 |
23922 |
0.26 |
chr19_24528181_24528407 | 10.48 |
Pip5k1b |
phosphatidylinositol-4-phosphate 5-kinase, type 1 beta |
27495 |
0.16 |
chr2_117185721_117185872 | 10.47 |
Mir674 |
microRNA 674 |
669 |
0.72 |
chr2_163574374_163574576 | 10.43 |
Hnf4a |
hepatic nuclear factor 4, alpha |
24392 |
0.11 |
chr2_132923726_132924027 | 10.42 |
Fermt1 |
fermitin family member 1 |
18087 |
0.14 |
chr4_135729412_135729596 | 10.40 |
Il22ra1 |
interleukin 22 receptor, alpha 1 |
1332 |
0.33 |
chr5_119071197_119071348 | 10.37 |
1700081H04Rik |
RIKEN cDNA 1700081H04 gene |
36962 |
0.18 |
chr2_143846814_143847098 | 10.36 |
Rps13-ps6 |
ribosomal protein S13, pseudogene 6 |
8693 |
0.15 |
chr2_22105469_22105620 | 10.36 |
Gm13337 |
predicted gene 13337 |
37718 |
0.22 |
chr9_64045641_64045837 | 10.34 |
Gm25606 |
predicted gene, 25606 |
2757 |
0.18 |
chr17_23555646_23555837 | 10.31 |
Casp16 |
caspase 16, apoptosis-related cysteine peptidase |
37 |
0.94 |
chr2_155553173_155553341 | 10.30 |
Acss2os |
acyl-CoA synthetase short-chain family member 2, opposite strand |
3673 |
0.1 |
chr18_74558201_74558408 | 10.30 |
1700120E14Rik |
RIKEN cDNA 1700120E14 gene |
27180 |
0.2 |
chr5_66079813_66079979 | 10.30 |
Rbm47 |
RNA binding motif protein 47 |
1088 |
0.39 |
chr10_6928920_6929071 | 10.30 |
Ipcef1 |
interaction protein for cytohesin exchange factors 1 |
50716 |
0.16 |
chr18_66476464_66476616 | 10.29 |
Gm50156 |
predicted gene, 50156 |
15331 |
0.11 |
chr13_4233227_4233430 | 10.28 |
Akr1c19 |
aldo-keto reductase family 1, member C19 |
412 |
0.79 |
chr15_54534137_54534505 | 10.24 |
Mal2 |
mal, T cell differentiation protein 2 |
36871 |
0.16 |
chr17_28817953_28818104 | 10.24 |
Brpf3 |
bromodomain and PHD finger containing, 3 |
308 |
0.81 |
chr17_23546226_23547548 | 10.24 |
6330415G19Rik |
RIKEN cDNA 6330415G19 gene |
3912 |
0.1 |
chr17_47454729_47455053 | 10.22 |
1700001C19Rik |
RIKEN cDNA 1700001C19 gene |
17515 |
0.11 |
chr5_143982467_143982628 | 10.21 |
Rsph10b |
radial spoke head 10 homolog B (Chlamydomonas) |
1395 |
0.25 |
chr12_33315305_33315597 | 10.21 |
Atxn7l1 |
ataxin 7-like 1 |
46 |
0.98 |
chr14_120337693_120337863 | 10.21 |
Mbnl2 |
muscleblind like splicing factor 2 |
31322 |
0.2 |
chr2_108236725_108236904 | 10.21 |
Gm13912 |
predicted gene 13912 |
54505 |
0.17 |
chr1_191283730_191283937 | 10.20 |
Gm37168 |
predicted gene, 37168 |
16655 |
0.13 |
chr11_54801905_54802095 | 10.19 |
Cdc42se2 |
CDC42 small effector 2 |
14325 |
0.13 |
chr17_3299635_3299796 | 10.18 |
Gm6475 |
predicted gene 6475 |
14470 |
0.15 |
chr17_47909349_47909983 | 10.17 |
Gm15556 |
predicted gene 15556 |
12712 |
0.13 |
chr11_79112308_79112500 | 10.11 |
Ksr1 |
kinase suppressor of ras 1 |
34003 |
0.16 |
chr14_14354416_14355184 | 10.11 |
Il3ra |
interleukin 3 receptor, alpha chain |
5179 |
0.12 |
chr3_49840937_49841092 | 10.10 |
Gm37550 |
predicted gene, 37550 |
60127 |
0.13 |
chr4_142221224_142221954 | 10.07 |
Kazn |
kazrin, periplakin interacting protein |
11383 |
0.22 |
chr5_146687980_146688258 | 10.06 |
4930573C15Rik |
RIKEN cDNA 4930573C15 gene |
18503 |
0.16 |
chr19_36371542_36371875 | 10.05 |
Pcgf5 |
polycomb group ring finger 5 |
7360 |
0.14 |
chr5_147993062_147993354 | 10.04 |
Mtus2 |
microtubule associated tumor suppressor candidate 2 |
35866 |
0.15 |
chr16_88599937_88600275 | 10.04 |
Gm49688 |
predicted gene, 49688 |
8564 |
0.11 |
chr12_85705262_85705591 | 10.00 |
Gm47285 |
predicted gene, 47285 |
13137 |
0.12 |
chr8_79301661_79301856 | 9.97 |
Gm4890 |
predicted gene 4890 |
6390 |
0.17 |
chr3_94049859_94050028 | 9.97 |
Tdpoz9 |
TD and POZ domain containing 9 |
270 |
0.81 |
chr12_69516626_69516826 | 9.96 |
5830428M24Rik |
RIKEN cDNA 5830428M24 gene |
41176 |
0.1 |
chr13_32831503_32831802 | 9.96 |
Wrnip1 |
Werner helicase interacting protein 1 |
10886 |
0.13 |
chr5_145116458_145116713 | 9.96 |
Arpc1b |
actin related protein 2/3 complex, subunit 1B |
2269 |
0.16 |
chr6_122591150_122591312 | 9.94 |
Apobec1 |
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1 |
8896 |
0.1 |
chr7_35116712_35116864 | 9.94 |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
2505 |
0.14 |
chr5_52360790_52361068 | 9.94 |
Sod3 |
superoxide dismutase 3, extracellular |
2862 |
0.21 |
chr7_79890546_79891013 | 9.93 |
Gm26646 |
predicted gene, 26646 |
26158 |
0.08 |
chr18_32035386_32035537 | 9.91 |
Myo7b |
myosin VIIB |
1500 |
0.29 |
chr4_82594396_82594548 | 9.91 |
Gm11267 |
predicted gene 11267 |
7153 |
0.23 |
chr11_120768274_120768442 | 9.90 |
Gm11771 |
predicted gene 11771 |
3048 |
0.1 |
chr10_20951881_20952964 | 9.88 |
Ahi1 |
Abelson helper integration site 1 |
125 |
0.97 |
chr15_36580548_36581460 | 9.88 |
Gm44310 |
predicted gene, 44310 |
2540 |
0.2 |
chr6_124738333_124739337 | 9.88 |
Ptpn6 |
protein tyrosine phosphatase, non-receptor type 6 |
121 |
0.85 |
chr16_33786732_33786885 | 9.86 |
Gm15657 |
predicted gene 15657 |
304 |
0.88 |
chr3_93938508_93938677 | 9.86 |
Gm9117 |
predicted pseudogene 9117 |
179 |
0.88 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.4 | 34.2 | GO:1902896 | terminal web assembly(GO:1902896) |
7.9 | 23.6 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
7.4 | 37.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
6.1 | 24.4 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
5.7 | 51.7 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
5.2 | 20.9 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
5.2 | 26.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
5.2 | 15.5 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
5.0 | 15.0 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
4.6 | 13.8 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
4.6 | 27.4 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
4.5 | 13.5 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
4.4 | 13.3 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
4.4 | 13.2 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
4.2 | 20.8 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
4.0 | 12.0 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
4.0 | 11.9 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
3.9 | 19.5 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
3.9 | 11.6 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
3.9 | 19.4 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
3.8 | 3.8 | GO:0044557 | relaxation of smooth muscle(GO:0044557) relaxation of vascular smooth muscle(GO:0060087) |
3.8 | 19.0 | GO:1904970 | brush border assembly(GO:1904970) |
3.8 | 11.3 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
3.8 | 3.8 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
3.7 | 11.2 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
3.7 | 3.7 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
3.7 | 14.7 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
3.7 | 3.7 | GO:0032532 | regulation of microvillus length(GO:0032532) |
3.6 | 25.5 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
3.6 | 10.9 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
3.6 | 10.7 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
3.5 | 10.5 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
3.5 | 10.5 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
3.5 | 7.0 | GO:0002159 | desmosome assembly(GO:0002159) |
3.5 | 10.5 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
3.5 | 10.5 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
3.4 | 10.2 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
3.4 | 10.1 | GO:0009804 | coumarin metabolic process(GO:0009804) |
3.4 | 10.1 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
3.3 | 10.0 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
3.3 | 10.0 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
3.3 | 19.9 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
3.3 | 9.9 | GO:0036394 | amylase secretion(GO:0036394) |
3.3 | 6.6 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
3.3 | 16.5 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
3.3 | 13.1 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
3.2 | 12.9 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
3.2 | 3.2 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
3.2 | 15.9 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
3.2 | 12.7 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
3.1 | 9.4 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
3.1 | 9.3 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
3.1 | 24.8 | GO:0070269 | pyroptosis(GO:0070269) |
3.1 | 3.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
3.1 | 9.3 | GO:0046865 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
3.1 | 12.4 | GO:0061325 | cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
3.1 | 9.2 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
3.1 | 3.1 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
3.0 | 9.1 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
3.0 | 9.1 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
3.0 | 6.0 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
3.0 | 9.0 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
3.0 | 26.8 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
3.0 | 6.0 | GO:0051784 | negative regulation of nuclear division(GO:0051784) |
3.0 | 3.0 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
3.0 | 11.8 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
3.0 | 8.9 | GO:0035483 | gastric emptying(GO:0035483) |
2.9 | 8.8 | GO:0032439 | endosome localization(GO:0032439) |
2.9 | 2.9 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
2.9 | 5.9 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
2.9 | 8.8 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
2.9 | 8.8 | GO:0048320 | axial mesoderm formation(GO:0048320) |
2.9 | 8.8 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
2.9 | 8.8 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
2.9 | 11.7 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
2.9 | 5.8 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
2.9 | 8.7 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
2.9 | 11.6 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
2.9 | 8.6 | GO:0070836 | caveola assembly(GO:0070836) |
2.8 | 14.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
2.8 | 2.8 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
2.8 | 8.5 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
2.8 | 8.4 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
2.8 | 14.0 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) |
2.8 | 11.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
2.8 | 5.6 | GO:0052490 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
2.8 | 2.8 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
2.7 | 10.9 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
2.7 | 10.9 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
2.7 | 10.9 | GO:0006742 | NADP catabolic process(GO:0006742) |
2.7 | 8.2 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
2.7 | 16.2 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
2.7 | 10.8 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
2.6 | 5.2 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
2.6 | 7.8 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
2.6 | 2.6 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
2.5 | 5.1 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
2.5 | 10.1 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
2.5 | 7.5 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
2.5 | 5.0 | GO:0046104 | thymidine metabolic process(GO:0046104) |
2.5 | 14.9 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
2.5 | 7.4 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
2.5 | 9.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
2.5 | 12.4 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
2.5 | 4.9 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
2.5 | 7.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
2.5 | 36.8 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
2.4 | 9.8 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
2.4 | 7.3 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
2.4 | 9.6 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
2.4 | 7.2 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
2.4 | 9.6 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
2.4 | 7.2 | GO:0010046 | response to mycotoxin(GO:0010046) |
2.4 | 16.7 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
2.4 | 16.7 | GO:0060613 | fat pad development(GO:0060613) |
2.4 | 7.1 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
2.4 | 7.1 | GO:0008050 | female courtship behavior(GO:0008050) |
2.4 | 4.7 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
2.3 | 9.4 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
2.3 | 14.0 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
2.3 | 7.0 | GO:0072092 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
2.3 | 2.3 | GO:0006083 | acetate metabolic process(GO:0006083) |
2.3 | 7.0 | GO:0018992 | germ-line sex determination(GO:0018992) |
2.3 | 6.9 | GO:0072592 | oxygen metabolic process(GO:0072592) |
2.3 | 11.5 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
2.3 | 18.4 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
2.3 | 13.8 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
2.3 | 6.8 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
2.3 | 6.8 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
2.3 | 2.3 | GO:0045472 | response to ether(GO:0045472) |
2.3 | 13.6 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
2.2 | 15.7 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
2.2 | 20.0 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
2.2 | 11.1 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
2.2 | 17.7 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
2.2 | 11.0 | GO:0016139 | glycoside catabolic process(GO:0016139) |
2.2 | 8.7 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
2.2 | 8.7 | GO:0051031 | tRNA transport(GO:0051031) |
2.2 | 4.4 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
2.2 | 8.7 | GO:0007296 | vitellogenesis(GO:0007296) |
2.2 | 4.3 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
2.2 | 6.5 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
2.2 | 4.3 | GO:0002432 | granuloma formation(GO:0002432) |
2.2 | 10.8 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
2.2 | 38.8 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
2.2 | 6.5 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
2.2 | 8.6 | GO:0006116 | NADH oxidation(GO:0006116) |
2.1 | 8.6 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
2.1 | 10.7 | GO:0051639 | actin filament network formation(GO:0051639) |
2.1 | 6.4 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
2.1 | 6.4 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
2.1 | 2.1 | GO:1903052 | positive regulation of proteolysis involved in cellular protein catabolic process(GO:1903052) |
2.1 | 4.2 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
2.1 | 6.3 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
2.1 | 14.8 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
2.1 | 2.1 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
2.1 | 12.5 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
2.1 | 6.2 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
2.1 | 4.1 | GO:1903751 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
2.1 | 6.2 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
2.1 | 8.3 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
2.1 | 2.1 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) positive regulation by host of viral process(GO:0044794) positive regulation of viral release from host cell(GO:1902188) |
2.1 | 4.1 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
2.1 | 6.2 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
2.1 | 6.2 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
2.1 | 10.3 | GO:0030259 | lipid glycosylation(GO:0030259) |
2.0 | 6.1 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
2.0 | 6.1 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
2.0 | 2.0 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
2.0 | 5.9 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
2.0 | 9.9 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
2.0 | 13.7 | GO:0032782 | bile acid secretion(GO:0032782) |
1.9 | 13.6 | GO:0099515 | actin filament-based transport(GO:0099515) |
1.9 | 1.9 | GO:0006109 | regulation of carbohydrate metabolic process(GO:0006109) |
1.9 | 25.2 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
1.9 | 3.9 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
1.9 | 3.9 | GO:0051593 | response to folic acid(GO:0051593) |
1.9 | 7.7 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
1.9 | 5.8 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.9 | 5.8 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
1.9 | 5.7 | GO:0061623 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
1.9 | 5.7 | GO:0000087 | mitotic M phase(GO:0000087) |
1.9 | 9.5 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
1.9 | 13.3 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
1.9 | 3.8 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
1.9 | 13.2 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
1.9 | 7.5 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
1.9 | 7.5 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
1.9 | 18.8 | GO:0010226 | response to lithium ion(GO:0010226) |
1.9 | 5.6 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
1.9 | 1.9 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
1.8 | 5.5 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
1.8 | 14.7 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
1.8 | 5.5 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.8 | 11.0 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
1.8 | 7.3 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
1.8 | 9.1 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
1.8 | 5.4 | GO:1903416 | response to glycoside(GO:1903416) |
1.8 | 5.4 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
1.8 | 3.6 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
1.8 | 3.6 | GO:0038091 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
1.8 | 1.8 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
1.8 | 1.8 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
1.8 | 16.1 | GO:0000103 | sulfate assimilation(GO:0000103) |
1.8 | 7.2 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
1.8 | 10.7 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
1.8 | 5.4 | GO:0030576 | Cajal body organization(GO:0030576) |
1.8 | 7.1 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
1.8 | 8.9 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
1.8 | 3.5 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
1.8 | 19.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
1.8 | 3.5 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
1.8 | 17.7 | GO:0034063 | stress granule assembly(GO:0034063) |
1.8 | 5.3 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
1.8 | 7.1 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
1.8 | 5.3 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
1.8 | 5.3 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
1.8 | 7.0 | GO:0019530 | taurine metabolic process(GO:0019530) |
1.8 | 28.1 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
1.7 | 7.0 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
1.7 | 1.7 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
1.7 | 5.2 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
1.7 | 7.0 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
1.7 | 6.9 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
1.7 | 6.9 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
1.7 | 5.2 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
1.7 | 5.2 | GO:0031296 | B cell costimulation(GO:0031296) |
1.7 | 8.6 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
1.7 | 5.2 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
1.7 | 1.7 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
1.7 | 6.8 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
1.7 | 3.4 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
1.7 | 1.7 | GO:0010390 | histone monoubiquitination(GO:0010390) |
1.7 | 1.7 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
1.7 | 3.4 | GO:0006868 | glutamine transport(GO:0006868) |
1.7 | 1.7 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
1.7 | 1.7 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
1.7 | 5.1 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
1.7 | 6.7 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
1.7 | 1.7 | GO:0090239 | regulation of histone H4 acetylation(GO:0090239) |
1.7 | 1.7 | GO:0070827 | chromatin maintenance(GO:0070827) |
1.7 | 5.0 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
1.7 | 3.3 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
1.7 | 5.0 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
1.7 | 5.0 | GO:0015888 | thiamine transport(GO:0015888) |
1.7 | 5.0 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
1.7 | 6.6 | GO:0032776 | DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) |
1.6 | 3.3 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
1.6 | 1.6 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
1.6 | 3.3 | GO:0010878 | cholesterol storage(GO:0010878) positive regulation of cholesterol storage(GO:0010886) |
1.6 | 1.6 | GO:0060065 | uterus development(GO:0060065) |
1.6 | 8.2 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
1.6 | 13.0 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
1.6 | 3.3 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
1.6 | 19.5 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
1.6 | 3.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
1.6 | 1.6 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
1.6 | 3.2 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
1.6 | 4.9 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
1.6 | 1.6 | GO:0030575 | nuclear body organization(GO:0030575) |
1.6 | 6.5 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
1.6 | 3.2 | GO:0042505 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
1.6 | 9.6 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
1.6 | 6.4 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
1.6 | 3.2 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
1.6 | 3.2 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
1.6 | 1.6 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
1.6 | 3.2 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
1.6 | 8.0 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
1.6 | 1.6 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
1.6 | 3.2 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
1.6 | 6.3 | GO:0034214 | protein hexamerization(GO:0034214) |
1.6 | 1.6 | GO:2000449 | regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
1.6 | 4.7 | GO:1904752 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
1.6 | 1.6 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
1.6 | 6.3 | GO:0072675 | osteoclast fusion(GO:0072675) |
1.6 | 18.9 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
1.6 | 3.1 | GO:0071280 | cellular response to copper ion(GO:0071280) |
1.6 | 4.7 | GO:0032730 | positive regulation of interleukin-1 alpha production(GO:0032730) |
1.6 | 6.2 | GO:0008355 | olfactory learning(GO:0008355) |
1.6 | 9.4 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
1.6 | 4.7 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
1.6 | 1.6 | GO:0070640 | vitamin D3 metabolic process(GO:0070640) |
1.5 | 15.5 | GO:0070293 | renal absorption(GO:0070293) |
1.5 | 10.8 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
1.5 | 1.5 | GO:0003352 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
1.5 | 6.1 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
1.5 | 3.1 | GO:0065001 | specification of axis polarity(GO:0065001) |
1.5 | 6.1 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
1.5 | 10.7 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
1.5 | 1.5 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
1.5 | 7.6 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
1.5 | 18.2 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
1.5 | 3.0 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
1.5 | 4.5 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
1.5 | 1.5 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
1.5 | 4.5 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
1.5 | 6.0 | GO:1903911 | positive regulation of postsynaptic membrane organization(GO:1901628) positive regulation of receptor clustering(GO:1903911) regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
1.5 | 4.5 | GO:0015755 | fructose transport(GO:0015755) |
1.5 | 1.5 | GO:0019086 | late viral transcription(GO:0019086) |
1.5 | 7.4 | GO:0070475 | rRNA base methylation(GO:0070475) |
1.5 | 4.5 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
1.5 | 3.0 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
1.5 | 4.4 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
1.5 | 16.3 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
1.5 | 3.0 | GO:0006566 | threonine metabolic process(GO:0006566) |
1.5 | 4.4 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
1.5 | 1.5 | GO:0034436 | glycoprotein transport(GO:0034436) |
1.5 | 3.0 | GO:0034165 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
1.5 | 1.5 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
1.5 | 1.5 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
1.5 | 4.4 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
1.5 | 4.4 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
1.5 | 14.7 | GO:0006903 | vesicle targeting(GO:0006903) |
1.5 | 1.5 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
1.5 | 8.8 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
1.5 | 1.5 | GO:0051702 | interaction with symbiont(GO:0051702) |
1.5 | 8.7 | GO:0006013 | mannose metabolic process(GO:0006013) |
1.4 | 5.8 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
1.4 | 11.5 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
1.4 | 15.8 | GO:0051546 | keratinocyte migration(GO:0051546) |
1.4 | 4.3 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
1.4 | 1.4 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
1.4 | 4.3 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
1.4 | 4.3 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
1.4 | 5.7 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
1.4 | 32.7 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
1.4 | 4.3 | GO:0000212 | meiotic spindle organization(GO:0000212) |
1.4 | 5.7 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
1.4 | 11.3 | GO:1901028 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901028) |
1.4 | 9.9 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
1.4 | 11.2 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
1.4 | 2.8 | GO:0071895 | odontoblast differentiation(GO:0071895) |
1.4 | 7.0 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
1.4 | 1.4 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
1.4 | 4.2 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
1.4 | 1.4 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
1.4 | 1.4 | GO:0010888 | negative regulation of lipid storage(GO:0010888) |
1.4 | 2.8 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
1.4 | 5.5 | GO:0042637 | catagen(GO:0042637) |
1.4 | 1.4 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
1.4 | 20.7 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
1.4 | 5.5 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
1.4 | 1.4 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
1.4 | 5.5 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
1.4 | 11.0 | GO:0034311 | sphingosine metabolic process(GO:0006670) diol metabolic process(GO:0034311) |
1.4 | 11.0 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
1.4 | 12.4 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
1.4 | 1.4 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
1.4 | 1.4 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
1.4 | 4.1 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
1.4 | 4.1 | GO:0046060 | dATP metabolic process(GO:0046060) |
1.4 | 1.4 | GO:0060155 | platelet dense granule organization(GO:0060155) |
1.4 | 1.4 | GO:0032610 | interleukin-1 alpha production(GO:0032610) |
1.4 | 4.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
1.4 | 1.4 | GO:0036258 | multivesicular body organization(GO:0036257) multivesicular body assembly(GO:0036258) |
1.4 | 1.4 | GO:2000591 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
1.4 | 2.7 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
1.4 | 2.7 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
1.4 | 2.7 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
1.4 | 5.4 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
1.3 | 4.0 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
1.3 | 2.7 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
1.3 | 1.3 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
1.3 | 1.3 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
1.3 | 10.7 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
1.3 | 1.3 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
1.3 | 1.3 | GO:0050872 | white fat cell differentiation(GO:0050872) |
1.3 | 4.0 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
1.3 | 2.7 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
1.3 | 2.7 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
1.3 | 4.0 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
1.3 | 2.6 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
1.3 | 5.3 | GO:0009597 | detection of virus(GO:0009597) |
1.3 | 1.3 | GO:0048311 | mitochondrion distribution(GO:0048311) |
1.3 | 4.0 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
1.3 | 13.2 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
1.3 | 2.6 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
1.3 | 1.3 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
1.3 | 1.3 | GO:0044241 | lipid digestion(GO:0044241) |
1.3 | 3.9 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
1.3 | 3.9 | GO:0072039 | regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072039) negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072040) mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:1901145) regulation of somatic stem cell population maintenance(GO:1904672) negative regulation of somatic stem cell population maintenance(GO:1904673) |
1.3 | 2.6 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.3 | 5.2 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
1.3 | 3.9 | GO:0001555 | oocyte growth(GO:0001555) |
1.3 | 14.1 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
1.3 | 1.3 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
1.3 | 1.3 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
1.3 | 2.6 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
1.3 | 7.7 | GO:0070327 | thyroid hormone transport(GO:0070327) |
1.3 | 1.3 | GO:0035315 | hair cell differentiation(GO:0035315) |
1.3 | 7.7 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
1.3 | 6.4 | GO:0033572 | transferrin transport(GO:0033572) |
1.3 | 3.8 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
1.3 | 2.6 | GO:0071455 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
1.3 | 6.4 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
1.3 | 12.7 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
1.3 | 3.8 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
1.3 | 13.9 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
1.3 | 27.8 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
1.3 | 5.1 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
1.3 | 7.5 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
1.2 | 3.7 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
1.2 | 16.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
1.2 | 2.5 | GO:0048143 | astrocyte activation(GO:0048143) |
1.2 | 7.4 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
1.2 | 5.0 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
1.2 | 21.0 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
1.2 | 8.7 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
1.2 | 3.7 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
1.2 | 2.5 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
1.2 | 9.9 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
1.2 | 7.4 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
1.2 | 9.8 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
1.2 | 6.1 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
1.2 | 7.3 | GO:0042737 | drug catabolic process(GO:0042737) |
1.2 | 1.2 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
1.2 | 2.4 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
1.2 | 1.2 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
1.2 | 3.6 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
1.2 | 4.8 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
1.2 | 3.6 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
1.2 | 3.6 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
1.2 | 4.8 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
1.2 | 3.6 | GO:0046386 | deoxyribose phosphate catabolic process(GO:0046386) |
1.2 | 1.2 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
1.2 | 2.4 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
1.2 | 4.7 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
1.2 | 3.6 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
1.2 | 4.7 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
1.2 | 4.7 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
1.2 | 3.6 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
1.2 | 3.6 | GO:0045080 | chemokine biosynthetic process(GO:0042033) regulation of chemokine biosynthetic process(GO:0045073) positive regulation of chemokine biosynthetic process(GO:0045080) |
1.2 | 21.3 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
1.2 | 3.5 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
1.2 | 3.5 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
1.2 | 16.5 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
1.2 | 9.4 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
1.2 | 3.5 | GO:0042256 | mature ribosome assembly(GO:0042256) |
1.2 | 4.7 | GO:0090527 | actin filament reorganization(GO:0090527) |
1.2 | 3.5 | GO:0018343 | protein farnesylation(GO:0018343) |
1.2 | 3.5 | GO:0090032 | negative regulation of steroid hormone biosynthetic process(GO:0090032) |
1.2 | 7.0 | GO:0070986 | left/right axis specification(GO:0070986) |
1.2 | 3.5 | GO:1903299 | regulation of hexokinase activity(GO:1903299) |
1.2 | 1.2 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
1.2 | 4.7 | GO:0021571 | rhombomere 5 development(GO:0021571) |
1.2 | 5.8 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
1.2 | 4.7 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
1.2 | 1.2 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
1.2 | 2.3 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
1.2 | 15.1 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
1.2 | 2.3 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
1.2 | 2.3 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
1.2 | 4.6 | GO:0007144 | female meiosis I(GO:0007144) |
1.2 | 4.6 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
1.2 | 9.2 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
1.1 | 8.0 | GO:0010869 | regulation of receptor biosynthetic process(GO:0010869) |
1.1 | 1.1 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
1.1 | 8.0 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
1.1 | 6.9 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
1.1 | 8.0 | GO:0035878 | nail development(GO:0035878) |
1.1 | 3.4 | GO:1903232 | melanosome assembly(GO:1903232) |
1.1 | 11.4 | GO:0070828 | heterochromatin organization(GO:0070828) |
1.1 | 3.4 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
1.1 | 4.5 | GO:0051444 | negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
1.1 | 3.4 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
1.1 | 1.1 | GO:0021570 | rhombomere 4 development(GO:0021570) |
1.1 | 2.2 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
1.1 | 2.2 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
1.1 | 2.2 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
1.1 | 3.3 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
1.1 | 3.3 | GO:0006857 | oligopeptide transport(GO:0006857) |
1.1 | 6.6 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
1.1 | 2.2 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
1.1 | 2.2 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
1.1 | 2.2 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
1.1 | 6.6 | GO:0051764 | actin crosslink formation(GO:0051764) |
1.1 | 3.3 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
1.1 | 1.1 | GO:0018904 | ether metabolic process(GO:0018904) |
1.1 | 15.4 | GO:0033622 | integrin activation(GO:0033622) |
1.1 | 6.6 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
1.1 | 7.7 | GO:0006907 | pinocytosis(GO:0006907) |
1.1 | 2.2 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
1.1 | 4.4 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
1.1 | 5.4 | GO:0007343 | egg activation(GO:0007343) |
1.1 | 4.3 | GO:1902224 | ketone body metabolic process(GO:1902224) |
1.1 | 2.2 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
1.1 | 7.5 | GO:0070914 | UV-damage excision repair(GO:0070914) |
1.1 | 3.2 | GO:1903332 | regulation of protein folding(GO:1903332) negative regulation of protein folding(GO:1903333) |
1.1 | 5.4 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
1.1 | 3.2 | GO:1900048 | positive regulation of blood coagulation(GO:0030194) positive regulation of coagulation(GO:0050820) positive regulation of hemostasis(GO:1900048) |
1.1 | 2.1 | GO:0033092 | positive regulation of immature T cell proliferation(GO:0033091) positive regulation of immature T cell proliferation in thymus(GO:0033092) |
1.1 | 20.3 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
1.1 | 1.1 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
1.1 | 21.3 | GO:0034340 | response to type I interferon(GO:0034340) |
1.1 | 2.1 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
1.1 | 10.6 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
1.1 | 5.3 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
1.1 | 3.2 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
1.1 | 2.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
1.1 | 1.1 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
1.1 | 1.1 | GO:0071335 | hair follicle cell proliferation(GO:0071335) |
1.1 | 6.3 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
1.1 | 41.1 | GO:0006749 | glutathione metabolic process(GO:0006749) |
1.1 | 3.2 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
1.1 | 4.2 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
1.1 | 14.7 | GO:0051923 | sulfation(GO:0051923) |
1.1 | 6.3 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
1.0 | 2.1 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
1.0 | 4.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
1.0 | 3.1 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
1.0 | 13.6 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
1.0 | 3.1 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
1.0 | 3.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
1.0 | 1.0 | GO:0048865 | stem cell fate commitment(GO:0048865) |
1.0 | 3.1 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
1.0 | 14.5 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
1.0 | 4.2 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
1.0 | 3.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
1.0 | 7.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
1.0 | 1.0 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
1.0 | 1.0 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
1.0 | 3.1 | GO:0072718 | response to cisplatin(GO:0072718) |
1.0 | 2.0 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
1.0 | 5.1 | GO:0015871 | choline transport(GO:0015871) |
1.0 | 1.0 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
1.0 | 2.0 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
1.0 | 1.0 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
1.0 | 3.1 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
1.0 | 2.0 | GO:0010159 | specification of organ position(GO:0010159) |
1.0 | 8.1 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
1.0 | 9.1 | GO:0019985 | translesion synthesis(GO:0019985) |
1.0 | 3.0 | GO:0034473 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
1.0 | 8.1 | GO:0001771 | immunological synapse formation(GO:0001771) |
1.0 | 1.0 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
1.0 | 5.0 | GO:0001842 | neural fold formation(GO:0001842) |
1.0 | 6.0 | GO:0097345 | mitochondrial outer membrane permeabilization(GO:0097345) |
1.0 | 1.0 | GO:0033598 | mammary gland epithelial cell proliferation(GO:0033598) |
1.0 | 7.0 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
1.0 | 3.0 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
1.0 | 1.0 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
1.0 | 26.1 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
1.0 | 2.0 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
1.0 | 4.0 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
1.0 | 1.0 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
1.0 | 7.0 | GO:0030033 | microvillus assembly(GO:0030033) |
1.0 | 3.0 | GO:0030916 | otic vesicle formation(GO:0030916) |
1.0 | 4.0 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
1.0 | 5.0 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
1.0 | 3.0 | GO:0007386 | compartment pattern specification(GO:0007386) |
1.0 | 1.0 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
1.0 | 3.0 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
1.0 | 3.0 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
1.0 | 3.0 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
1.0 | 1.0 | GO:0019042 | viral latency(GO:0019042) |
1.0 | 3.0 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
1.0 | 4.9 | GO:0008340 | determination of adult lifespan(GO:0008340) |
1.0 | 2.0 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
1.0 | 4.9 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
1.0 | 2.0 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
1.0 | 3.9 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.0 | 19.6 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
1.0 | 1.0 | GO:0007418 | ventral midline development(GO:0007418) floor plate morphogenesis(GO:0033505) |
1.0 | 4.9 | GO:0006569 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
1.0 | 3.9 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
1.0 | 7.8 | GO:0042572 | retinol metabolic process(GO:0042572) |
1.0 | 2.0 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
1.0 | 1.0 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
1.0 | 1.9 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
1.0 | 2.9 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
1.0 | 3.9 | GO:0030299 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
1.0 | 1.9 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
1.0 | 12.5 | GO:0045116 | protein neddylation(GO:0045116) |
1.0 | 4.8 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
1.0 | 6.7 | GO:0046697 | decidualization(GO:0046697) |
1.0 | 1.9 | GO:0071265 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
1.0 | 2.9 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
1.0 | 6.7 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
1.0 | 6.7 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
1.0 | 6.7 | GO:0031167 | rRNA methylation(GO:0031167) |
1.0 | 9.5 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
1.0 | 16.2 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
1.0 | 4.8 | GO:0032691 | negative regulation of interleukin-1 beta production(GO:0032691) |
1.0 | 1.0 | GO:0036005 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.9 | 2.8 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.9 | 5.7 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) DNA endoreduplication(GO:0042023) |
0.9 | 0.9 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.9 | 3.8 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.9 | 0.9 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.9 | 5.6 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.9 | 5.6 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.9 | 1.9 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
0.9 | 0.9 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.9 | 2.8 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.9 | 5.6 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.9 | 1.9 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.9 | 1.9 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.9 | 8.4 | GO:0034033 | coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.9 | 4.7 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.9 | 2.8 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.9 | 3.7 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.9 | 4.6 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.9 | 16.7 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.9 | 6.5 | GO:0002021 | response to dietary excess(GO:0002021) |
0.9 | 9.3 | GO:0080111 | DNA demethylation(GO:0080111) |
0.9 | 1.9 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) |
0.9 | 0.9 | GO:0010799 | regulation of peptidyl-threonine phosphorylation(GO:0010799) |
0.9 | 1.8 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.9 | 0.9 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.9 | 0.9 | GO:0015791 | polyol transport(GO:0015791) |
0.9 | 21.2 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.9 | 3.7 | GO:0060426 | lung vasculature development(GO:0060426) |
0.9 | 0.9 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.9 | 10.0 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.9 | 10.0 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.9 | 2.7 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.9 | 4.5 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.9 | 0.9 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.9 | 1.8 | GO:0006573 | valine metabolic process(GO:0006573) |
0.9 | 0.9 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.9 | 0.9 | GO:1902075 | cellular response to salt(GO:1902075) |
0.9 | 4.5 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.9 | 0.9 | GO:0072576 | liver morphogenesis(GO:0072576) |
0.9 | 3.6 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.9 | 25.9 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.9 | 1.8 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.9 | 1.8 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.9 | 4.5 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.9 | 5.3 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.9 | 2.7 | GO:0008228 | opsonization(GO:0008228) |
0.9 | 1.8 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.9 | 1.8 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.9 | 0.9 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.9 | 2.6 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.9 | 5.3 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.9 | 9.7 | GO:0043248 | proteasome assembly(GO:0043248) |
0.9 | 6.2 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.9 | 8.8 | GO:0010613 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.9 | 0.9 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.9 | 8.8 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.9 | 20.2 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.9 | 1.8 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.9 | 4.4 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.9 | 2.6 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.9 | 0.9 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.9 | 7.0 | GO:0003334 | keratinocyte development(GO:0003334) |
0.9 | 1.7 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.9 | 1.7 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.9 | 7.0 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.9 | 7.8 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.9 | 1.7 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.9 | 1.7 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.9 | 1.7 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) |
0.9 | 8.6 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.9 | 3.4 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.9 | 3.4 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.9 | 0.9 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.9 | 6.0 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.9 | 11.1 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.9 | 4.3 | GO:0060068 | vagina development(GO:0060068) |
0.9 | 28.1 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.8 | 5.1 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.8 | 5.1 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.8 | 0.8 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.8 | 0.8 | GO:0097205 | renal filtration(GO:0097205) |
0.8 | 2.5 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.8 | 1.7 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.8 | 1.7 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.8 | 10.1 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.8 | 3.4 | GO:0016264 | gap junction assembly(GO:0016264) |
0.8 | 5.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.8 | 1.7 | GO:0006971 | hypotonic response(GO:0006971) |
0.8 | 5.0 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.8 | 3.4 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.8 | 2.5 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.8 | 1.7 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.8 | 4.2 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.8 | 0.8 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.8 | 3.3 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.8 | 1.7 | GO:0051340 | regulation of ligase activity(GO:0051340) |
0.8 | 2.5 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.8 | 7.4 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.8 | 2.5 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.8 | 3.3 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.8 | 0.8 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.8 | 1.6 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.8 | 0.8 | GO:2000665 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) regulation of interleukin-13 secretion(GO:2000665) |
0.8 | 0.8 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.8 | 0.8 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.8 | 0.8 | GO:0043622 | cortical microtubule organization(GO:0043622) |
0.8 | 1.6 | GO:0002295 | T-helper cell lineage commitment(GO:0002295) T-helper 17 cell lineage commitment(GO:0072540) |
0.8 | 4.1 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.8 | 1.6 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.8 | 0.8 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.8 | 3.2 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.8 | 2.4 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.8 | 1.6 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.8 | 1.6 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.8 | 0.8 | GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway(GO:0090081) positive regulation of heart induction(GO:1901321) |
0.8 | 4.0 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.8 | 4.8 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.8 | 4.8 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.8 | 1.6 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.8 | 1.6 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.8 | 1.6 | GO:0048536 | spleen development(GO:0048536) |
0.8 | 2.4 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.8 | 1.6 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.8 | 3.2 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.8 | 2.4 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.8 | 5.6 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.8 | 3.2 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.8 | 2.4 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.8 | 0.8 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.8 | 2.4 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.8 | 0.8 | GO:0032094 | response to food(GO:0032094) |
0.8 | 3.9 | GO:0097421 | liver regeneration(GO:0097421) |
0.8 | 2.3 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.8 | 0.8 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.8 | 3.1 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.8 | 0.8 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.8 | 1.6 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.8 | 6.2 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.8 | 2.3 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.8 | 2.3 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.8 | 2.3 | GO:0033504 | floor plate development(GO:0033504) |
0.8 | 9.3 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.8 | 0.8 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.8 | 1.6 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.8 | 10.1 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.8 | 2.3 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.8 | 7.7 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.8 | 3.1 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.8 | 4.6 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.8 | 4.6 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.8 | 2.3 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.8 | 2.3 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
0.8 | 0.8 | GO:0002863 | positive regulation of inflammatory response to antigenic stimulus(GO:0002863) |
0.8 | 13.0 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.8 | 0.8 | GO:0006403 | RNA localization(GO:0006403) |
0.8 | 6.1 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.8 | 6.1 | GO:0010388 | cullin deneddylation(GO:0010388) |
0.8 | 4.6 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.8 | 7.6 | GO:0070633 | transepithelial transport(GO:0070633) |
0.8 | 16.8 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.8 | 2.3 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.8 | 1.5 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.8 | 0.8 | GO:0060416 | response to growth hormone(GO:0060416) |
0.8 | 3.8 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.8 | 4.5 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.8 | 1.5 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.8 | 1.5 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.8 | 3.0 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.8 | 0.8 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.8 | 3.8 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.8 | 2.3 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.8 | 1.5 | GO:1901679 | pyrimidine-containing compound transmembrane transport(GO:0072531) nucleotide transmembrane transport(GO:1901679) |
0.8 | 3.8 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.8 | 0.8 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.7 | 0.7 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.7 | 1.5 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.7 | 4.5 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.7 | 0.7 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.7 | 1.5 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.7 | 4.4 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.7 | 3.0 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.7 | 1.5 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.7 | 0.7 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.7 | 1.5 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.7 | 2.2 | GO:0071679 | commissural neuron axon guidance(GO:0071679) |
0.7 | 0.7 | GO:0052173 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.7 | 1.5 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.7 | 8.1 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.7 | 4.4 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.7 | 0.7 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.7 | 5.8 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.7 | 0.7 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.7 | 0.7 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.7 | 8.0 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.7 | 1.5 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.7 | 1.5 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.7 | 2.9 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.7 | 5.8 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.7 | 0.7 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.7 | 3.6 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.7 | 3.6 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.7 | 0.7 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
0.7 | 0.7 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.7 | 1.4 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.7 | 0.7 | GO:0050955 | thermoception(GO:0050955) |
0.7 | 1.4 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.7 | 13.4 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.7 | 4.2 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.7 | 5.6 | GO:0002076 | osteoblast development(GO:0002076) |
0.7 | 2.1 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.7 | 0.7 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.7 | 0.7 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.7 | 3.5 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) |
0.7 | 1.4 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.7 | 1.4 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.7 | 4.9 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.7 | 0.7 | GO:2000437 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
0.7 | 4.2 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.7 | 2.1 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.7 | 1.4 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.7 | 2.8 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.7 | 1.4 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.7 | 2.1 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.7 | 0.7 | GO:0042938 | dipeptide transport(GO:0042938) |
0.7 | 2.1 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.7 | 0.7 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.7 | 3.4 | GO:0071569 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.7 | 1.4 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.7 | 3.4 | GO:0015825 | L-serine transport(GO:0015825) |
0.7 | 2.0 | GO:0060023 | soft palate development(GO:0060023) |
0.7 | 2.0 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) |
0.7 | 2.0 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.7 | 0.7 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.7 | 2.0 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.7 | 4.1 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.7 | 1.4 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.7 | 2.7 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.7 | 0.7 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.7 | 0.7 | GO:0007619 | courtship behavior(GO:0007619) |
0.7 | 0.7 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.7 | 2.0 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.7 | 2.0 | GO:1903393 | positive regulation of adherens junction organization(GO:1903393) |
0.7 | 0.7 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.7 | 8.1 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.7 | 5.4 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.7 | 4.0 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.7 | 6.7 | GO:0071549 | response to dexamethasone(GO:0071548) cellular response to dexamethasone stimulus(GO:0071549) |
0.7 | 2.7 | GO:0044038 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.7 | 3.3 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.7 | 0.7 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.7 | 0.7 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.7 | 0.7 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.7 | 1.3 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.7 | 0.7 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.7 | 0.7 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
0.7 | 20.7 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.7 | 2.0 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.7 | 0.7 | GO:0032907 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
0.7 | 4.0 | GO:0046688 | response to copper ion(GO:0046688) |
0.7 | 2.0 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.7 | 0.7 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.7 | 0.7 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.7 | 0.7 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.7 | 3.9 | GO:2000758 | positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.7 | 2.0 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.7 | 11.8 | GO:0060323 | head morphogenesis(GO:0060323) |
0.7 | 3.9 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.7 | 2.6 | GO:0035112 | genitalia morphogenesis(GO:0035112) |
0.7 | 1.3 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.6 | 0.6 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.6 | 5.8 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.6 | 0.6 | GO:0031639 | plasminogen activation(GO:0031639) |
0.6 | 0.6 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.6 | 0.6 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
0.6 | 1.3 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.6 | 4.5 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
0.6 | 5.1 | GO:0006228 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) |
0.6 | 1.9 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.6 | 8.4 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.6 | 3.9 | GO:0051026 | chiasma assembly(GO:0051026) |
0.6 | 3.9 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.6 | 0.6 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.6 | 18.0 | GO:0003382 | epithelial cell morphogenesis(GO:0003382) |
0.6 | 1.3 | GO:0051782 | negative regulation of cell division(GO:0051782) |
0.6 | 0.6 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
0.6 | 7.7 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.6 | 0.6 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.6 | 5.7 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.6 | 3.8 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.6 | 0.6 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.6 | 1.3 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.6 | 5.7 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.6 | 2.5 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.6 | 0.6 | GO:0032720 | negative regulation of tumor necrosis factor production(GO:0032720) |
0.6 | 0.6 | GO:0031056 | regulation of histone modification(GO:0031056) |
0.6 | 6.9 | GO:0017144 | drug metabolic process(GO:0017144) |
0.6 | 1.9 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.6 | 22.5 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.6 | 1.9 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.6 | 1.9 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.6 | 1.2 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.6 | 1.2 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.6 | 32.9 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.6 | 1.9 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.6 | 1.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.6 | 1.9 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.6 | 0.6 | GO:2000489 | regulation of hepatic stellate cell activation(GO:2000489) |
0.6 | 2.5 | GO:0051798 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.6 | 1.9 | GO:0042640 | anagen(GO:0042640) |
0.6 | 6.8 | GO:0051875 | pigment granule localization(GO:0051875) |
0.6 | 3.1 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.6 | 4.3 | GO:0007097 | nuclear migration(GO:0007097) |
0.6 | 1.2 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.6 | 4.9 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.6 | 1.2 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.6 | 1.8 | GO:0060056 | mammary gland involution(GO:0060056) |
0.6 | 2.4 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.6 | 2.4 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.6 | 1.2 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.6 | 3.7 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.6 | 1.2 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.6 | 1.2 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.6 | 1.8 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.6 | 0.6 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.6 | 0.6 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.6 | 4.2 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.6 | 1.2 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.6 | 0.6 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.6 | 4.8 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.6 | 4.2 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.6 | 1.2 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.6 | 1.2 | GO:1902745 | positive regulation of lamellipodium organization(GO:1902745) |
0.6 | 4.2 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.6 | 0.6 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.6 | 0.6 | GO:0071025 | RNA surveillance(GO:0071025) |
0.6 | 8.3 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.6 | 1.2 | GO:0034115 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.6 | 1.2 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.6 | 3.5 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.6 | 12.4 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.6 | 0.6 | GO:0045341 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.6 | 1.2 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.6 | 9.9 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.6 | 1.7 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.6 | 12.7 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
0.6 | 1.7 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.6 | 0.6 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.6 | 0.6 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.6 | 1.2 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.6 | 2.3 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.6 | 1.1 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.6 | 1.7 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.6 | 1.7 | GO:0072553 | terminal button organization(GO:0072553) |
0.6 | 1.7 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.6 | 0.6 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.6 | 1.7 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.6 | 1.1 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.6 | 1.7 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.6 | 1.7 | GO:0021898 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.6 | 3.4 | GO:0050832 | defense response to fungus(GO:0050832) |
0.6 | 1.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.6 | 2.3 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.6 | 0.6 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.6 | 0.6 | GO:0006241 | CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) |
0.6 | 1.1 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.6 | 0.6 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.6 | 5.6 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) |
0.6 | 3.9 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.6 | 1.1 | GO:0033762 | response to glucagon(GO:0033762) |
0.6 | 6.1 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.6 | 17.2 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) |
0.6 | 0.6 | GO:1902309 | regulation of peptidyl-serine dephosphorylation(GO:1902308) negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.6 | 1.7 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.6 | 1.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.6 | 2.8 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.6 | 1.1 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.6 | 1.1 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.6 | 3.9 | GO:0006790 | sulfur compound metabolic process(GO:0006790) |
0.6 | 2.2 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.6 | 2.2 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.6 | 0.6 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.5 | 1.1 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) |
0.5 | 8.2 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.5 | 1.1 | GO:2000301 | negative regulation of synaptic vesicle transport(GO:1902804) negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.5 | 1.6 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.5 | 1.1 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.5 | 9.8 | GO:0044784 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
0.5 | 1.1 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.5 | 1.1 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.5 | 1.6 | GO:0010039 | response to iron ion(GO:0010039) |
0.5 | 0.5 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.5 | 2.2 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.5 | 0.5 | GO:2000427 | regulation of apoptotic cell clearance(GO:2000425) positive regulation of apoptotic cell clearance(GO:2000427) |
0.5 | 1.6 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.5 | 1.6 | GO:1901341 | positive regulation of store-operated calcium channel activity(GO:1901341) |
0.5 | 5.4 | GO:0071451 | cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
0.5 | 0.5 | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.5 | 2.7 | GO:0032060 | bleb assembly(GO:0032060) |
0.5 | 1.1 | GO:0045911 | positive regulation of DNA recombination(GO:0045911) |
0.5 | 4.3 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.5 | 3.8 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.5 | 2.7 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.5 | 1.1 | GO:0048102 | autophagic cell death(GO:0048102) |
0.5 | 2.1 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.5 | 3.2 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.5 | 3.7 | GO:0070266 | necroptotic process(GO:0070266) |
0.5 | 3.7 | GO:0090224 | regulation of spindle organization(GO:0090224) |
0.5 | 2.7 | GO:0043372 | positive regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043372) |
0.5 | 0.5 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.5 | 0.5 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.5 | 2.6 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.5 | 1.1 | GO:0045684 | positive regulation of epidermis development(GO:0045684) |
0.5 | 1.1 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.5 | 1.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.5 | 1.1 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.5 | 4.2 | GO:0009648 | photoperiodism(GO:0009648) |
0.5 | 1.0 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.5 | 1.0 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.5 | 2.6 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.5 | 4.2 | GO:0051601 | exocyst localization(GO:0051601) |
0.5 | 0.5 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.5 | 0.5 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.5 | 1.6 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.5 | 2.6 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.5 | 6.7 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.5 | 0.5 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.5 | 7.2 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.5 | 1.0 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.5 | 1.5 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.5 | 1.5 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.5 | 0.5 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.5 | 2.5 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.5 | 0.5 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.5 | 0.5 | GO:0033058 | directional locomotion(GO:0033058) |
0.5 | 1.5 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.5 | 0.5 | GO:0046888 | negative regulation of hormone secretion(GO:0046888) |
0.5 | 2.0 | GO:0051458 | corticotropin secretion(GO:0051458) |
0.5 | 4.0 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.5 | 1.0 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.5 | 0.5 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.5 | 1.5 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.5 | 1.0 | GO:0014857 | regulation of skeletal muscle cell proliferation(GO:0014857) |
0.5 | 21.6 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) |
0.5 | 0.5 | GO:0002934 | desmosome organization(GO:0002934) |
0.5 | 8.5 | GO:0010827 | regulation of glucose transport(GO:0010827) |
0.5 | 7.0 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.5 | 1.0 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.5 | 0.5 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.5 | 1.0 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.5 | 3.5 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.5 | 1.0 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.5 | 0.5 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.5 | 2.0 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.5 | 0.5 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.5 | 2.0 | GO:0009299 | mRNA transcription(GO:0009299) |
0.5 | 2.5 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.5 | 1.5 | GO:0001893 | maternal placenta development(GO:0001893) |
0.5 | 3.9 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.5 | 2.0 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.5 | 1.0 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.5 | 1.0 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) |
0.5 | 2.0 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.5 | 0.5 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.5 | 2.9 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.5 | 0.5 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.5 | 1.5 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.5 | 5.3 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.5 | 0.5 | GO:2000851 | positive regulation of glucocorticoid secretion(GO:2000851) |
0.5 | 4.4 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.5 | 1.0 | GO:1903998 | regulation of eating behavior(GO:1903998) negative regulation of eating behavior(GO:1903999) |
0.5 | 1.5 | GO:0045453 | bone resorption(GO:0045453) |
0.5 | 1.0 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
0.5 | 0.5 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.5 | 1.0 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.5 | 1.4 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.5 | 3.4 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.5 | 1.0 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.5 | 1.4 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.5 | 1.0 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.5 | 1.0 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.5 | 6.2 | GO:0031648 | protein destabilization(GO:0031648) |
0.5 | 0.5 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) dorsal root ganglion development(GO:1990791) |
0.5 | 0.5 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.5 | 2.4 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.5 | 6.7 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.5 | 4.8 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.5 | 1.0 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.5 | 0.5 | GO:1903170 | negative regulation of calcium ion transmembrane transport(GO:1903170) |
0.5 | 0.5 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.5 | 4.3 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.5 | 1.9 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.5 | 1.4 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.5 | 0.9 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.5 | 0.5 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.5 | 2.8 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.5 | 0.5 | GO:0043482 | endosome to melanosome transport(GO:0035646) cellular pigment accumulation(GO:0043482) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.5 | 2.8 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.5 | 2.3 | GO:0016266 | O-glycan processing(GO:0016266) |
0.5 | 0.5 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.5 | 3.3 | GO:0001945 | lymph vessel development(GO:0001945) |
0.5 | 5.6 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.5 | 4.7 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.5 | 0.9 | GO:0030813 | positive regulation of nucleotide catabolic process(GO:0030813) |
0.5 | 1.9 | GO:0030888 | regulation of B cell proliferation(GO:0030888) |
0.5 | 0.9 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.5 | 1.9 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.5 | 0.5 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.5 | 2.3 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.5 | 13.8 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.5 | 4.1 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.5 | 1.8 | GO:0035437 | maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.5 | 3.7 | GO:0044804 | nucleophagy(GO:0044804) |
0.5 | 0.9 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.5 | 0.9 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.5 | 2.7 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.5 | 4.1 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.5 | 0.5 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.5 | 1.4 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.5 | 7.7 | GO:0016180 | snRNA processing(GO:0016180) |
0.5 | 5.4 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.5 | 2.3 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.5 | 0.5 | GO:0030878 | thyroid gland development(GO:0030878) |
0.4 | 3.1 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
0.4 | 3.1 | GO:0032205 | negative regulation of telomere maintenance(GO:0032205) |
0.4 | 2.2 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.4 | 2.7 | GO:0045056 | transcytosis(GO:0045056) |
0.4 | 0.4 | GO:0009148 | pyrimidine nucleoside triphosphate biosynthetic process(GO:0009148) |
0.4 | 5.4 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.4 | 0.4 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.4 | 0.4 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.4 | 0.4 | GO:0060324 | face development(GO:0060324) |
0.4 | 4.4 | GO:0007595 | lactation(GO:0007595) |
0.4 | 0.9 | GO:0072757 | cellular response to camptothecin(GO:0072757) |
0.4 | 19.8 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.4 | 1.3 | GO:0008272 | sulfate transport(GO:0008272) |
0.4 | 1.3 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.4 | 3.1 | GO:0016926 | protein desumoylation(GO:0016926) |
0.4 | 1.3 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.4 | 2.6 | GO:0043535 | regulation of blood vessel endothelial cell migration(GO:0043535) |
0.4 | 0.4 | GO:0032252 | secretory granule localization(GO:0032252) |
0.4 | 3.5 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.4 | 0.9 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.4 | 1.3 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.4 | 2.2 | GO:0050892 | intestinal absorption(GO:0050892) |
0.4 | 2.2 | GO:0034204 | lipid translocation(GO:0034204) |
0.4 | 3.5 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.4 | 0.4 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.4 | 4.7 | GO:0006465 | signal peptide processing(GO:0006465) |
0.4 | 1.3 | GO:0032823 | regulation of natural killer cell differentiation(GO:0032823) |
0.4 | 0.4 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.4 | 1.7 | GO:1900271 | regulation of long-term synaptic potentiation(GO:1900271) |
0.4 | 5.6 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.4 | 0.9 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.4 | 2.1 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) |
0.4 | 1.3 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.4 | 0.9 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.4 | 6.4 | GO:0035148 | tube formation(GO:0035148) |
0.4 | 2.5 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.4 | 0.8 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.4 | 0.4 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.4 | 0.4 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.4 | 2.1 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.4 | 2.1 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.4 | 1.3 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.4 | 0.4 | GO:0046533 | negative regulation of photoreceptor cell differentiation(GO:0046533) retinal rod cell differentiation(GO:0060221) |
0.4 | 0.4 | GO:0002830 | positive regulation of type 2 immune response(GO:0002830) |
0.4 | 0.4 | GO:0048753 | positive regulation of melanin biosynthetic process(GO:0048023) pigment granule organization(GO:0048753) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.4 | 2.9 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.4 | 7.9 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.4 | 0.4 | GO:0060967 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by miRNA(GO:0060965) negative regulation of gene silencing by RNA(GO:0060967) |
0.4 | 1.2 | GO:0002645 | positive regulation of tolerance induction(GO:0002645) positive regulation of T cell tolerance induction(GO:0002666) |
0.4 | 0.8 | GO:0003264 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) regulation of secondary heart field cardioblast proliferation(GO:0003266) |
0.4 | 0.4 | GO:2000737 | negative regulation of stem cell differentiation(GO:2000737) |
0.4 | 0.4 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.4 | 0.4 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.4 | 1.6 | GO:0090189 | regulation of branching involved in ureteric bud morphogenesis(GO:0090189) |
0.4 | 1.2 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.4 | 0.4 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.4 | 9.8 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.4 | 2.5 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.4 | 0.8 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
0.4 | 2.9 | GO:0043489 | RNA stabilization(GO:0043489) |
0.4 | 0.4 | GO:0019740 | nitrogen utilization(GO:0019740) ammonium transmembrane transport(GO:0072488) |
0.4 | 2.8 | GO:0031297 | replication fork processing(GO:0031297) |
0.4 | 0.4 | GO:0060022 | hard palate development(GO:0060022) |
0.4 | 1.2 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.4 | 5.3 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.4 | 0.8 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.4 | 0.8 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.4 | 0.8 | GO:0044550 | melanin biosynthetic process(GO:0042438) secondary metabolite biosynthetic process(GO:0044550) |
0.4 | 3.2 | GO:0051383 | kinetochore organization(GO:0051383) |
0.4 | 10.1 | GO:0007569 | cell aging(GO:0007569) |
0.4 | 1.2 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.4 | 0.8 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.4 | 0.4 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.4 | 2.0 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.4 | 2.0 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.4 | 2.4 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.4 | 3.2 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) skeletal muscle adaptation(GO:0043501) |
0.4 | 0.8 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.4 | 4.0 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.4 | 3.6 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.4 | 2.0 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
0.4 | 0.8 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.4 | 2.0 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.4 | 1.6 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.4 | 11.4 | GO:0007041 | lysosomal transport(GO:0007041) |
0.4 | 0.8 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.4 | 4.3 | GO:0043297 | apical junction assembly(GO:0043297) |
0.4 | 1.6 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.4 | 0.8 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.4 | 1.6 | GO:0051972 | regulation of telomerase activity(GO:0051972) |
0.4 | 0.8 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.4 | 0.8 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.4 | 0.8 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.4 | 1.5 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.4 | 3.5 | GO:1901072 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) glucosamine-containing compound catabolic process(GO:1901072) |
0.4 | 0.8 | GO:0030238 | male sex determination(GO:0030238) |
0.4 | 1.2 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.4 | 0.4 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.4 | 1.5 | GO:0045576 | mast cell activation(GO:0045576) |
0.4 | 2.3 | GO:0002385 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.4 | 9.1 | GO:0042073 | intraciliary transport(GO:0042073) |
0.4 | 0.8 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.4 | 10.9 | GO:0006970 | response to osmotic stress(GO:0006970) |
0.4 | 0.8 | GO:0009174 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.4 | 9.0 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.4 | 3.0 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.4 | 0.7 | GO:0036486 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
0.4 | 2.6 | GO:0032418 | lysosome localization(GO:0032418) |
0.4 | 1.9 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.4 | 3.0 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.4 | 2.2 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.4 | 7.1 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.4 | 4.1 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.4 | 0.4 | GO:0070417 | cellular response to cold(GO:0070417) |
0.4 | 0.4 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.4 | 0.7 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.4 | 0.4 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.4 | 3.3 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.4 | 2.6 | GO:0097009 | energy homeostasis(GO:0097009) |
0.4 | 1.1 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.4 | 1.8 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.4 | 2.9 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.4 | 1.8 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.4 | 0.4 | GO:0044849 | estrous cycle(GO:0044849) |
0.4 | 0.7 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.4 | 2.2 | GO:0030539 | male genitalia development(GO:0030539) |
0.4 | 11.9 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.4 | 0.7 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.4 | 27.3 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.4 | 2.5 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.4 | 1.8 | GO:0031398 | positive regulation of protein ubiquitination(GO:0031398) |
0.4 | 0.4 | GO:0046271 | phenylpropanoid metabolic process(GO:0009698) phenylpropanoid catabolic process(GO:0046271) |
0.4 | 1.4 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.4 | 1.1 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.4 | 0.7 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.3 | 0.7 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.3 | 4.5 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.3 | 0.3 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.3 | 4.2 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.3 | 1.0 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.3 | 40.8 | GO:0051607 | defense response to virus(GO:0051607) |
0.3 | 0.3 | GO:0000959 | mitochondrial RNA metabolic process(GO:0000959) |
0.3 | 1.0 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.3 | 3.1 | GO:0048535 | lymph node development(GO:0048535) |
0.3 | 1.4 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.3 | 1.0 | GO:0060005 | vestibular reflex(GO:0060005) |
0.3 | 1.0 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.3 | 2.1 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.3 | 0.3 | GO:0036314 | response to sterol(GO:0036314) |
0.3 | 0.7 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.3 | 6.1 | GO:0052696 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.3 | 0.3 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.3 | 1.4 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.3 | 2.4 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.3 | 7.1 | GO:0009060 | aerobic respiration(GO:0009060) |
0.3 | 0.7 | GO:0072530 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.3 | 2.0 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.3 | 1.0 | GO:0034505 | tooth mineralization(GO:0034505) |
0.3 | 0.3 | GO:0002467 | germinal center formation(GO:0002467) |
0.3 | 0.3 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.3 | 1.3 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.3 | 4.7 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.3 | 0.7 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.3 | 1.3 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.3 | 0.7 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.3 | 3.0 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.3 | 1.0 | GO:0009409 | response to cold(GO:0009409) |
0.3 | 1.3 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.3 | 0.7 | GO:0071725 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.3 | 0.3 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.3 | 0.3 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.3 | 7.9 | GO:0031424 | keratinization(GO:0031424) |
0.3 | 0.3 | GO:0014870 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to stimulus involved in regulation of muscle adaptation(GO:0014874) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.3 | 1.0 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.3 | 0.7 | GO:0048254 | snoRNA localization(GO:0048254) |
0.3 | 0.3 | GO:2000679 | positive regulation of transcription regulatory region DNA binding(GO:2000679) |
0.3 | 1.0 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.3 | 1.0 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.3 | 0.3 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.3 | 0.3 | GO:0060290 | transdifferentiation(GO:0060290) |
0.3 | 0.3 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.3 | 4.2 | GO:0034605 | cellular response to heat(GO:0034605) |
0.3 | 2.6 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.3 | 1.6 | GO:0044088 | regulation of vacuole organization(GO:0044088) |
0.3 | 1.0 | GO:0006273 | lagging strand elongation(GO:0006273) |
0.3 | 3.5 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.3 | 0.6 | GO:1901724 | positive regulation of cell proliferation involved in kidney development(GO:1901724) |
0.3 | 6.1 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.3 | 0.3 | GO:0060027 | convergent extension involved in gastrulation(GO:0060027) |
0.3 | 7.3 | GO:0032024 | positive regulation of insulin secretion(GO:0032024) |
0.3 | 0.6 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.3 | 0.6 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.3 | 0.3 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.3 | 1.6 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.3 | 1.3 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.3 | 3.8 | GO:0015893 | drug transport(GO:0015893) |
0.3 | 0.9 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.3 | 0.9 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.3 | 0.9 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.3 | 0.6 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.3 | 0.6 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.3 | 0.3 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) cellular response to vitamin D(GO:0071305) |
0.3 | 0.6 | GO:0043206 | extracellular fibril organization(GO:0043206) fibril organization(GO:0097435) |
0.3 | 0.9 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.3 | 0.9 | GO:0009101 | glycoprotein biosynthetic process(GO:0009101) |
0.3 | 0.9 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.3 | 1.5 | GO:0002861 | regulation of inflammatory response to antigenic stimulus(GO:0002861) negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.3 | 0.6 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.3 | 2.8 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.3 | 2.1 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.3 | 2.8 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.3 | 0.9 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.3 | 4.0 | GO:0015914 | phospholipid transport(GO:0015914) |
0.3 | 0.3 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.3 | 0.3 | GO:0046632 | alpha-beta T cell differentiation(GO:0046632) |
0.3 | 0.6 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.3 | 13.1 | GO:0016042 | lipid catabolic process(GO:0016042) |
0.3 | 1.2 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.3 | 0.3 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.3 | 2.4 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.3 | 1.5 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.3 | 1.2 | GO:0002507 | tolerance induction(GO:0002507) |
0.3 | 3.6 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.3 | 1.2 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.3 | 0.9 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.3 | 1.8 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.3 | 0.3 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.3 | 0.6 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.3 | 0.6 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.3 | 0.3 | GO:0045974 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.3 | 2.1 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.3 | 1.2 | GO:0036035 | osteoclast development(GO:0036035) |
0.3 | 0.6 | GO:0009650 | UV protection(GO:0009650) |
0.3 | 0.6 | GO:0033280 | response to vitamin D(GO:0033280) |
0.3 | 6.3 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.3 | 0.3 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.3 | 0.9 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.3 | 3.1 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.3 | 0.6 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.3 | 1.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.3 | 1.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.3 | 1.1 | GO:0019319 | hexose biosynthetic process(GO:0019319) |
0.3 | 0.6 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.3 | 0.3 | GO:0022616 | DNA strand elongation(GO:0022616) |
0.3 | 2.0 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.3 | 4.8 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.3 | 0.6 | GO:0023058 | adaptation of signaling pathway(GO:0023058) |
0.3 | 0.3 | GO:0046886 | positive regulation of hormone biosynthetic process(GO:0046886) |
0.3 | 3.6 | GO:0042168 | heme metabolic process(GO:0042168) |
0.3 | 0.3 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.3 | 0.3 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.3 | 0.3 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.3 | 0.8 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.3 | 0.3 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.3 | 1.4 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.3 | 0.8 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.3 | 1.3 | GO:0070232 | regulation of T cell apoptotic process(GO:0070232) |
0.3 | 0.3 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.3 | 1.6 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.3 | 1.1 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.3 | 0.3 | GO:0070741 | response to interleukin-6(GO:0070741) |
0.3 | 8.5 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.3 | 1.1 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.3 | 0.3 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.3 | 1.6 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.3 | 1.1 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.3 | 0.8 | GO:0034397 | telomere localization(GO:0034397) |
0.3 | 1.0 | GO:0021591 | ventricular system development(GO:0021591) |
0.3 | 6.0 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.3 | 0.5 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.3 | 1.5 | GO:0072595 | maintenance of protein location in nucleus(GO:0051457) maintenance of protein localization in organelle(GO:0072595) |
0.3 | 1.5 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.3 | 1.3 | GO:0007379 | segment specification(GO:0007379) |
0.3 | 0.8 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.3 | 1.0 | GO:0042730 | fibrinolysis(GO:0042730) |
0.3 | 1.8 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.3 | 2.0 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.3 | 2.5 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.3 | 4.3 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.3 | 15.5 | GO:0051236 | establishment of RNA localization(GO:0051236) |
0.3 | 1.3 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.3 | 0.3 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
0.2 | 0.5 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.2 | 10.0 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.2 | 1.0 | GO:0030104 | water homeostasis(GO:0030104) |
0.2 | 0.7 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.2 | 1.7 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.2 | 2.2 | GO:0006643 | membrane lipid metabolic process(GO:0006643) |
0.2 | 0.2 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 0.5 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.2 | 0.5 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.2 | 0.7 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.2 | 0.7 | GO:0050818 | regulation of coagulation(GO:0050818) |
0.2 | 0.5 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.2 | 0.5 | GO:0048525 | negative regulation of viral process(GO:0048525) |
0.2 | 0.7 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.2 | 0.5 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.2 | 0.7 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.2 | 2.2 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.2 | 3.6 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.2 | 0.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.2 | 0.5 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.2 | 0.2 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.2 | 1.2 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.2 | 0.2 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.2 | 1.9 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.2 | 0.5 | GO:0032608 | interferon-beta production(GO:0032608) regulation of interferon-beta production(GO:0032648) |
0.2 | 0.5 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
0.2 | 32.5 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
0.2 | 0.9 | GO:0007320 | insemination(GO:0007320) |
0.2 | 34.2 | GO:0006897 | endocytosis(GO:0006897) |
0.2 | 4.4 | GO:0031214 | biomineral tissue development(GO:0031214) |
0.2 | 1.2 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.2 | 0.2 | GO:0072210 | metanephric nephron development(GO:0072210) |
0.2 | 0.5 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.2 | 0.5 | GO:0038066 | p38MAPK cascade(GO:0038066) |
0.2 | 1.2 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.2 | 0.2 | GO:0000237 | leptotene(GO:0000237) |
0.2 | 0.2 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.2 | 4.8 | GO:0034341 | response to interferon-gamma(GO:0034341) |
0.2 | 0.5 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
0.2 | 0.2 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.2 | 0.5 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.2 | 2.0 | GO:0050709 | negative regulation of protein secretion(GO:0050709) |
0.2 | 0.5 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.2 | 1.6 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.2 | 0.2 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.2 | 0.2 | GO:0090178 | regulation of establishment of planar polarity involved in neural tube closure(GO:0090178) |
0.2 | 1.1 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.2 | 0.9 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.2 | 0.9 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.2 | 0.9 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.2 | 4.0 | GO:0030834 | regulation of actin filament depolymerization(GO:0030834) |
0.2 | 1.1 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.2 | 6.9 | GO:0008643 | carbohydrate transport(GO:0008643) |
0.2 | 0.4 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.2 | 2.4 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.2 | 0.9 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.2 | 0.7 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.2 | 0.7 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.2 | 0.9 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.2 | 1.5 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
0.2 | 0.4 | GO:0097028 | dendritic cell differentiation(GO:0097028) |
0.2 | 1.5 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.2 | 0.4 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 0.9 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.2 | 0.4 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.2 | 2.2 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.2 | 10.4 | GO:0008033 | tRNA processing(GO:0008033) |
0.2 | 0.6 | GO:0009084 | glutamine family amino acid biosynthetic process(GO:0009084) |
0.2 | 0.2 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.2 | 0.2 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.2 | 0.2 | GO:0061009 | common bile duct development(GO:0061009) |
0.2 | 1.3 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.2 | 0.2 | GO:0072422 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.2 | 0.2 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.2 | 0.2 | GO:0043586 | tongue development(GO:0043586) |
0.2 | 0.8 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.2 | 9.9 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.2 | 0.2 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.2 | 0.4 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.2 | 0.4 | GO:0043409 | negative regulation of MAPK cascade(GO:0043409) |
0.2 | 0.2 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.2 | 0.2 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.2 | 1.5 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.2 | 3.3 | GO:0048017 | inositol lipid-mediated signaling(GO:0048017) |
0.2 | 0.6 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.2 | 0.2 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
0.2 | 0.2 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.2 | 2.7 | GO:0010906 | regulation of glucose metabolic process(GO:0010906) |
0.2 | 0.2 | GO:0040031 | snRNA modification(GO:0040031) |
0.2 | 0.8 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.2 | 0.2 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.2 | 2.8 | GO:0042107 | cytokine metabolic process(GO:0042107) |
0.2 | 0.2 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.2 | 0.2 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.2 | 0.4 | GO:0072501 | cellular divalent inorganic anion homeostasis(GO:0072501) |
0.2 | 1.2 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.2 | 0.4 | GO:0016556 | mRNA modification(GO:0016556) |
0.2 | 0.6 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.2 | 1.2 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.2 | 5.8 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.2 | 0.4 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.2 | 0.2 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.2 | 0.2 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.2 | 1.6 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.2 | 0.6 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.2 | 2.1 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.2 | 0.4 | GO:0010921 | regulation of phosphatase activity(GO:0010921) |
0.2 | 2.9 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.2 | 0.2 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.2 | 0.2 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 0.6 | GO:1990089 | response to nerve growth factor(GO:1990089) cellular response to nerve growth factor stimulus(GO:1990090) |
0.2 | 5.0 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.2 | 1.9 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.2 | 1.7 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.2 | 0.4 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 0.2 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.2 | 0.2 | GO:0090281 | negative regulation of calcium ion import(GO:0090281) |
0.2 | 0.2 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.2 | 0.2 | GO:0061370 | testosterone biosynthetic process(GO:0061370) regulation of testosterone biosynthetic process(GO:2000224) |
0.2 | 0.2 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.2 | 0.2 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) regulation of collateral sprouting in absence of injury(GO:0048696) |
0.2 | 0.2 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.2 | 0.2 | GO:0060841 | venous blood vessel development(GO:0060841) |
0.2 | 0.2 | GO:0010889 | regulation of sequestering of triglyceride(GO:0010889) |
0.2 | 0.7 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.2 | 0.2 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.2 | 0.5 | GO:0015074 | DNA integration(GO:0015074) |
0.2 | 4.4 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.2 | 0.5 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.2 | 0.5 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 0.2 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.2 | 0.7 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.2 | 0.4 | GO:0033865 | nucleoside bisphosphate metabolic process(GO:0033865) ribonucleoside bisphosphate metabolic process(GO:0033875) purine nucleoside bisphosphate metabolic process(GO:0034032) |
0.2 | 1.4 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.2 | 0.2 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.2 | 0.9 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.2 | 4.2 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.2 | 3.0 | GO:1901998 | toxin transport(GO:1901998) |
0.2 | 1.9 | GO:0009615 | response to virus(GO:0009615) |
0.2 | 0.3 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.2 | 1.9 | GO:0048144 | fibroblast proliferation(GO:0048144) |
0.2 | 20.9 | GO:0008380 | RNA splicing(GO:0008380) |
0.2 | 0.2 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.2 | 1.2 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.2 | 0.2 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.2 | 0.5 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.2 | 0.3 | GO:0045924 | regulation of female receptivity(GO:0045924) |
0.2 | 1.8 | GO:0019216 | regulation of lipid metabolic process(GO:0019216) |
0.2 | 1.0 | GO:0048538 | thymus development(GO:0048538) |
0.2 | 1.5 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.2 | 1.5 | GO:0030201 | heparan sulfate proteoglycan metabolic process(GO:0030201) |
0.2 | 0.7 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.2 | 3.4 | GO:0001824 | blastocyst development(GO:0001824) |
0.2 | 0.2 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.2 | 0.2 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.2 | 2.5 | GO:0001541 | ovarian follicle development(GO:0001541) |
0.2 | 0.8 | GO:0048678 | response to axon injury(GO:0048678) |
0.2 | 2.2 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.2 | 0.2 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.2 | 0.9 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.2 | 0.5 | GO:0000578 | embryonic axis specification(GO:0000578) |
0.2 | 0.5 | GO:0035306 | positive regulation of dephosphorylation(GO:0035306) |
0.2 | 4.3 | GO:0001101 | response to acid chemical(GO:0001101) |
0.2 | 0.2 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) |
0.2 | 0.2 | GO:0006266 | DNA ligation(GO:0006266) |
0.2 | 0.3 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.2 | 0.3 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 0.8 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.2 | 1.7 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.2 | 15.2 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.1 | 0.7 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.1 | 0.6 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.1 | 4.2 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.6 | GO:1901660 | calcium ion export(GO:1901660) |
0.1 | 2.2 | GO:0009988 | cell-cell recognition(GO:0009988) |
0.1 | 0.9 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.7 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.1 | 0.1 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.1 | 1.7 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
0.1 | 1.3 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.1 | 6.4 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.1 | 0.1 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.1 | 0.3 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.1 | 0.3 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.1 | 0.3 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.1 | 0.1 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.1 | 0.1 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
0.1 | 0.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.1 | 2.0 | GO:0006165 | nucleoside diphosphate phosphorylation(GO:0006165) |
0.1 | 0.4 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.1 | 0.8 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.1 | GO:0032355 | response to estradiol(GO:0032355) |
0.1 | 0.1 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) vascular wound healing(GO:0061042) |
0.1 | 0.1 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.1 | 0.3 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.1 | 0.3 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 11.2 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
0.1 | 0.4 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.1 | GO:0060921 | sinoatrial node cell differentiation(GO:0060921) |
0.1 | 6.6 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.1 | 5.6 | GO:0006869 | lipid transport(GO:0006869) |
0.1 | 0.1 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.1 | 0.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.3 | GO:0014047 | glutamate secretion(GO:0014047) |
0.1 | 0.1 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.1 | 3.5 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.1 | 0.3 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.1 | 0.1 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.1 | 0.1 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.1 | 1.4 | GO:0007566 | embryo implantation(GO:0007566) |
0.1 | 2.7 | GO:0008610 | lipid biosynthetic process(GO:0008610) |
0.1 | 0.3 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.1 | 0.9 | GO:0010634 | positive regulation of epithelial cell migration(GO:0010634) |
0.1 | 0.4 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 2.3 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 1.0 | GO:0070229 | negative regulation of lymphocyte apoptotic process(GO:0070229) |
0.1 | 0.9 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.1 | 0.6 | GO:1903509 | liposaccharide metabolic process(GO:1903509) |
0.1 | 0.1 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.1 | 0.2 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.1 | 0.4 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.2 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.1 | 0.5 | GO:0007614 | short-term memory(GO:0007614) |
0.1 | 1.0 | GO:0030316 | osteoclast differentiation(GO:0030316) |
0.1 | 2.3 | GO:0007179 | transforming growth factor beta receptor signaling pathway(GO:0007179) |
0.1 | 0.5 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.1 | 0.1 | GO:0043276 | anoikis(GO:0043276) |
0.1 | 0.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 24.7 | GO:0048232 | male gamete generation(GO:0048232) |
0.1 | 0.2 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.1 | 0.2 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 0.4 | GO:1901031 | regulation of response to reactive oxygen species(GO:1901031) |
0.1 | 1.8 | GO:0003281 | ventricular septum development(GO:0003281) |
0.1 | 1.2 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.1 | 0.3 | GO:0051591 | response to cAMP(GO:0051591) |
0.1 | 0.1 | GO:0060926 | atrioventricular node development(GO:0003162) cardiac pacemaker cell differentiation(GO:0060920) cardiac pacemaker cell development(GO:0060926) |
0.1 | 0.3 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 | 0.1 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.1 | 0.2 | GO:0098659 | inorganic cation import into cell(GO:0098659) inorganic ion import into cell(GO:0099587) |
0.1 | 0.1 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.1 | 0.4 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.1 | 3.2 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.1 | 3.5 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.1 | 0.9 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.1 | 0.1 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.1 | GO:0006862 | nucleotide transport(GO:0006862) |
0.1 | 1.0 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.1 | 0.4 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.1 | 0.1 | GO:0072012 | glomerulus vasculature development(GO:0072012) |
0.1 | 0.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.4 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.2 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.1 | 1.4 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.1 | 0.1 | GO:0034390 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.1 | 0.4 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.1 | 0.4 | GO:0032924 | activin receptor signaling pathway(GO:0032924) |
0.1 | 0.3 | GO:0006536 | glutamate metabolic process(GO:0006536) |
0.1 | 0.4 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.4 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.1 | GO:0030279 | negative regulation of ossification(GO:0030279) |
0.1 | 0.1 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.1 | 0.1 | GO:0060251 | regulation of glial cell proliferation(GO:0060251) |
0.1 | 0.1 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.1 | 0.6 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.2 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.1 | 0.3 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.1 | 0.2 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 0.2 | GO:0098762 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.1 | 0.1 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 0.2 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.1 | 0.1 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.1 | 0.2 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 0.2 | GO:0042503 | tyrosine phosphorylation of Stat3 protein(GO:0042503) |
0.1 | 0.1 | GO:0070474 | positive regulation of uterine smooth muscle contraction(GO:0070474) |
0.1 | 0.4 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.1 | 0.1 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.1 | 0.1 | GO:0032528 | microvillus organization(GO:0032528) |
0.1 | 0.4 | GO:0001967 | suckling behavior(GO:0001967) |
0.1 | 0.2 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.1 | 0.2 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
0.1 | 0.1 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
0.1 | 2.2 | GO:0007599 | hemostasis(GO:0007599) |
0.1 | 0.1 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.1 | 0.3 | GO:0033198 | response to ATP(GO:0033198) |
0.1 | 0.2 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.1 | 0.7 | GO:0030203 | glycosaminoglycan metabolic process(GO:0030203) |
0.1 | 0.1 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.1 | 1.4 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.1 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.1 | GO:0015819 | lysine transport(GO:0015819) |
0.1 | 0.1 | GO:0042446 | hormone biosynthetic process(GO:0042446) |
0.1 | 0.5 | GO:0030574 | collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
0.1 | 7.2 | GO:0043086 | negative regulation of catalytic activity(GO:0043086) |
0.1 | 2.8 | GO:0030198 | extracellular matrix organization(GO:0030198) |
0.1 | 0.1 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.1 | 0.1 | GO:2001021 | negative regulation of response to DNA damage stimulus(GO:2001021) |
0.1 | 2.7 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.1 | 0.1 | GO:0000097 | sulfur amino acid biosynthetic process(GO:0000097) |
0.1 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 7.8 | GO:0005975 | carbohydrate metabolic process(GO:0005975) |
0.1 | 12.5 | GO:0055114 | oxidation-reduction process(GO:0055114) |
0.1 | 0.1 | GO:0014029 | neural crest formation(GO:0014029) |
0.1 | 0.1 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.1 | 0.3 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.1 | 0.2 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 4.8 | GO:0032259 | methylation(GO:0032259) |
0.1 | 0.2 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 0.1 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.1 | 0.1 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.1 | 0.1 | GO:0099624 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.1 | 0.1 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.1 | 0.1 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.1 | 0.1 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.1 | 0.1 | GO:2001179 | regulation of interleukin-10 secretion(GO:2001179) |
0.1 | 0.1 | GO:0001759 | organ induction(GO:0001759) |
0.1 | 0.1 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.5 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.0 | 0.3 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.0 | 0.0 | GO:0046135 | pyrimidine ribonucleoside catabolic process(GO:0046133) pyrimidine nucleoside catabolic process(GO:0046135) |
0.0 | 0.0 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.0 | 0.0 | GO:0009642 | response to light intensity(GO:0009642) |
0.0 | 0.0 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.0 | 0.1 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.0 | 0.0 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.0 | 0.0 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.0 | 0.2 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
0.0 | 0.1 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.0 | 0.2 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.0 | 0.0 | GO:0014009 | glial cell proliferation(GO:0014009) |
0.0 | 0.6 | GO:0015807 | L-amino acid transport(GO:0015807) |
0.0 | 0.2 | GO:0019081 | viral translation(GO:0019081) |
0.0 | 0.0 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.0 | 0.1 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.0 | 0.9 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.0 | 0.4 | GO:0019827 | stem cell population maintenance(GO:0019827) |
0.0 | 0.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.1 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.0 | 0.1 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.0 | 3.1 | GO:0044782 | cilium organization(GO:0044782) |
0.0 | 0.0 | GO:2000053 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
0.0 | 0.1 | GO:0033146 | regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
0.0 | 0.0 | GO:0070228 | regulation of lymphocyte apoptotic process(GO:0070228) |
0.0 | 0.0 | GO:0009620 | response to fungus(GO:0009620) |
0.0 | 0.3 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.0 | 0.0 | GO:0016559 | peroxisome fission(GO:0016559) |
0.0 | 0.1 | GO:1900182 | positive regulation of protein localization to nucleus(GO:1900182) |
0.0 | 0.0 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.0 | 2.9 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.1 | GO:0002274 | myeloid leukocyte activation(GO:0002274) |
0.0 | 0.0 | GO:0060947 | cardiac vascular smooth muscle cell differentiation(GO:0060947) |
0.0 | 0.1 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.0 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.0 | 0.0 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.0 | 0.0 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.0 | 0.0 | GO:0031069 | hair follicle morphogenesis(GO:0031069) epidermis morphogenesis(GO:0048730) |
0.0 | 0.0 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.0 | GO:0097300 | programmed necrotic cell death(GO:0097300) |
0.0 | 0.0 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.0 | 0.0 | GO:0050701 | interleukin-1 secretion(GO:0050701) |
0.0 | 0.6 | GO:0007605 | sensory perception of sound(GO:0007605) |
0.0 | 15.0 | GO:0007606 | sensory perception of chemical stimulus(GO:0007606) |
0.0 | 0.0 | GO:0045346 | regulation of MHC class II biosynthetic process(GO:0045346) |
0.0 | 0.5 | GO:0006821 | chloride transport(GO:0006821) |
0.0 | 0.0 | GO:0046849 | bone remodeling(GO:0046849) |
0.0 | 0.1 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.1 | 18.2 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
6.7 | 40.4 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
3.5 | 10.5 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
3.4 | 6.9 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
3.4 | 13.5 | GO:0061689 | tricellular tight junction(GO:0061689) |
3.2 | 9.6 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
3.2 | 25.5 | GO:0030056 | hemidesmosome(GO:0030056) |
3.2 | 19.1 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
3.2 | 9.5 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
3.1 | 3.1 | GO:0071986 | Ragulator complex(GO:0071986) |
3.1 | 18.9 | GO:0005915 | zonula adherens(GO:0005915) |
3.0 | 12.1 | GO:0030689 | Noc complex(GO:0030689) |
2.9 | 5.8 | GO:0031252 | cell leading edge(GO:0031252) |
2.8 | 11.3 | GO:0072487 | MSL complex(GO:0072487) |
2.8 | 8.3 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
2.6 | 23.7 | GO:0097470 | ribbon synapse(GO:0097470) |
2.5 | 10.0 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
2.5 | 9.9 | GO:0071141 | SMAD protein complex(GO:0071141) |
2.5 | 12.3 | GO:0001651 | dense fibrillar component(GO:0001651) |
2.4 | 4.9 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
2.4 | 9.7 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
2.3 | 30.5 | GO:0042589 | zymogen granule membrane(GO:0042589) |
2.3 | 11.6 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
2.3 | 9.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
2.3 | 2.3 | GO:0035861 | site of double-strand break(GO:0035861) |
2.3 | 4.5 | GO:0043219 | lateral loop(GO:0043219) |
2.3 | 9.1 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
2.2 | 9.0 | GO:0000938 | GARP complex(GO:0000938) |
2.2 | 2.2 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
2.2 | 8.9 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
2.2 | 6.6 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
2.2 | 10.8 | GO:0033093 | Weibel-Palade body(GO:0033093) |
2.1 | 261.1 | GO:0005903 | brush border(GO:0005903) |
2.1 | 6.3 | GO:0036064 | ciliary basal body(GO:0036064) |
2.1 | 2.1 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
2.0 | 13.9 | GO:0071437 | invadopodium(GO:0071437) |
2.0 | 3.9 | GO:0097427 | microtubule bundle(GO:0097427) |
1.9 | 13.4 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
1.9 | 30.1 | GO:0000421 | autophagosome membrane(GO:0000421) |
1.8 | 9.2 | GO:0005638 | lamin filament(GO:0005638) |
1.8 | 7.4 | GO:0000125 | PCAF complex(GO:0000125) |
1.8 | 9.2 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
1.8 | 5.5 | GO:0035061 | interchromatin granule(GO:0035061) |
1.8 | 9.1 | GO:0008091 | spectrin(GO:0008091) |
1.8 | 7.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
1.8 | 9.0 | GO:0030870 | Mre11 complex(GO:0030870) |
1.7 | 5.2 | GO:0000322 | storage vacuole(GO:0000322) |
1.7 | 12.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
1.7 | 8.5 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
1.6 | 11.5 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
1.6 | 27.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
1.6 | 6.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
1.6 | 4.7 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
1.5 | 4.6 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
1.5 | 91.0 | GO:0000118 | histone deacetylase complex(GO:0000118) |
1.5 | 4.6 | GO:1990357 | terminal web(GO:1990357) |
1.5 | 19.6 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
1.5 | 24.0 | GO:0002102 | podosome(GO:0002102) |
1.5 | 4.4 | GO:0005914 | spot adherens junction(GO:0005914) |
1.5 | 3.0 | GO:0070765 | gamma-secretase complex(GO:0070765) |
1.5 | 10.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
1.5 | 8.7 | GO:0005818 | aster(GO:0005818) |
1.5 | 37.7 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
1.4 | 2.9 | GO:0016272 | prefoldin complex(GO:0016272) |
1.4 | 5.7 | GO:1990246 | uniplex complex(GO:1990246) |
1.4 | 9.9 | GO:0042627 | chylomicron(GO:0042627) |
1.4 | 11.3 | GO:0044666 | MLL3/4 complex(GO:0044666) |
1.4 | 1.4 | GO:0005686 | U2 snRNP(GO:0005686) |
1.4 | 5.6 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
1.4 | 2.8 | GO:0097452 | GAIT complex(GO:0097452) |
1.4 | 4.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
1.4 | 2.7 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
1.4 | 24.3 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
1.3 | 4.0 | GO:0045298 | tubulin complex(GO:0045298) |
1.3 | 2.7 | GO:0036449 | microtubule minus-end(GO:0036449) |
1.3 | 5.3 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
1.3 | 4.0 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
1.3 | 10.5 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
1.3 | 6.6 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
1.3 | 13.1 | GO:0005687 | U4 snRNP(GO:0005687) |
1.3 | 10.2 | GO:0016600 | flotillin complex(GO:0016600) |
1.3 | 23.9 | GO:0030057 | desmosome(GO:0030057) |
1.2 | 1.2 | GO:0061574 | ASAP complex(GO:0061574) |
1.2 | 1.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
1.2 | 4.9 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
1.2 | 2.4 | GO:0016939 | kinesin II complex(GO:0016939) |
1.2 | 13.3 | GO:0035102 | PRC1 complex(GO:0035102) |
1.2 | 18.1 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
1.2 | 6.0 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
1.2 | 26.5 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
1.2 | 10.8 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
1.2 | 15.5 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
1.2 | 3.6 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
1.2 | 3.5 | GO:1990462 | omegasome(GO:1990462) |
1.2 | 3.5 | GO:0097413 | Lewy body(GO:0097413) |
1.2 | 3.5 | GO:0097441 | basilar dendrite(GO:0097441) |
1.2 | 12.9 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
1.2 | 15.0 | GO:0036038 | MKS complex(GO:0036038) |
1.1 | 3.4 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
1.1 | 4.5 | GO:0005642 | annulate lamellae(GO:0005642) |
1.1 | 2.3 | GO:0001739 | sex chromatin(GO:0001739) |
1.1 | 5.7 | GO:0032133 | chromosome passenger complex(GO:0032133) |
1.1 | 45.1 | GO:0045095 | keratin filament(GO:0045095) |
1.1 | 4.5 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
1.1 | 3.3 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
1.1 | 11.0 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
1.1 | 6.5 | GO:0045179 | apical cortex(GO:0045179) |
1.1 | 1.1 | GO:0012505 | endomembrane system(GO:0012505) |
1.1 | 15.1 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
1.1 | 16.0 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
1.1 | 10.6 | GO:0031932 | TORC2 complex(GO:0031932) |
1.1 | 3.2 | GO:0043293 | apoptosome(GO:0043293) |
1.1 | 7.4 | GO:0097539 | ciliary transition fiber(GO:0097539) |
1.0 | 8.3 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
1.0 | 5.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
1.0 | 3.1 | GO:0046691 | intracellular canaliculus(GO:0046691) |
1.0 | 12.3 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
1.0 | 4.1 | GO:0042583 | chromaffin granule(GO:0042583) |
1.0 | 3.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
1.0 | 10.1 | GO:0010369 | chromocenter(GO:0010369) |
1.0 | 2.0 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
1.0 | 5.1 | GO:0030027 | lamellipodium(GO:0030027) |
1.0 | 7.1 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
1.0 | 7.0 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
1.0 | 6.0 | GO:0000439 | core TFIIH complex(GO:0000439) |
1.0 | 2.0 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
1.0 | 22.8 | GO:0055038 | recycling endosome membrane(GO:0055038) |
1.0 | 6.9 | GO:0042382 | paraspeckles(GO:0042382) |
1.0 | 21.7 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
1.0 | 3.9 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
1.0 | 9.8 | GO:0000785 | chromatin(GO:0000785) |
1.0 | 6.8 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
1.0 | 1.9 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
1.0 | 19.4 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
1.0 | 10.6 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
1.0 | 2.9 | GO:0005726 | perichromatin fibrils(GO:0005726) |
1.0 | 1.9 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
1.0 | 3.8 | GO:0044294 | dendritic growth cone(GO:0044294) |
1.0 | 1.9 | GO:0030897 | HOPS complex(GO:0030897) |
1.0 | 3.8 | GO:0031983 | vesicle lumen(GO:0031983) |
1.0 | 2.9 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
1.0 | 39.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.9 | 4.7 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.9 | 7.5 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.9 | 15.0 | GO:0005884 | actin filament(GO:0005884) |
0.9 | 4.7 | GO:0016459 | myosin complex(GO:0016459) |
0.9 | 16.8 | GO:0045120 | pronucleus(GO:0045120) |
0.9 | 2.7 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.9 | 2.7 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.9 | 2.7 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.9 | 47.9 | GO:0016363 | nuclear matrix(GO:0016363) |
0.9 | 3.5 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.9 | 2.6 | GO:0005795 | Golgi stack(GO:0005795) |
0.9 | 17.3 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.9 | 6.9 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.9 | 0.9 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.9 | 12.0 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.9 | 12.8 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.9 | 39.1 | GO:0032587 | ruffle membrane(GO:0032587) |
0.8 | 0.8 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.8 | 2.5 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.8 | 1.7 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.8 | 9.1 | GO:0033391 | chromatoid body(GO:0033391) |
0.8 | 3.3 | GO:0033269 | internode region of axon(GO:0033269) |
0.8 | 4.1 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.8 | 8.2 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.8 | 0.8 | GO:0034399 | nuclear periphery(GO:0034399) |
0.8 | 5.7 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.8 | 17.1 | GO:0034451 | centriolar satellite(GO:0034451) |
0.8 | 3.2 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.8 | 1.6 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.8 | 4.0 | GO:0005827 | polar microtubule(GO:0005827) |
0.8 | 66.0 | GO:0043296 | apical junction complex(GO:0043296) |
0.8 | 2.4 | GO:0005955 | calcineurin complex(GO:0005955) |
0.8 | 6.3 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.8 | 1.6 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.8 | 2.4 | GO:0030891 | VCB complex(GO:0030891) |
0.8 | 24.2 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.8 | 11.7 | GO:0031430 | M band(GO:0031430) |
0.8 | 2.3 | GO:0044327 | dendritic spine head(GO:0044327) |
0.8 | 3.1 | GO:0097542 | ciliary tip(GO:0097542) |
0.8 | 0.8 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.8 | 3.1 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.8 | 4.6 | GO:0070847 | core mediator complex(GO:0070847) |
0.8 | 1.5 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.8 | 0.8 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.8 | 3.8 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.8 | 0.8 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.8 | 37.8 | GO:0005811 | lipid particle(GO:0005811) |
0.7 | 1.5 | GO:0036157 | outer dynein arm(GO:0036157) |
0.7 | 0.7 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.7 | 8.1 | GO:1902554 | serine/threonine protein kinase complex(GO:1902554) |
0.7 | 5.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.7 | 2.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.7 | 2.2 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.7 | 2.9 | GO:0005916 | fascia adherens(GO:0005916) |
0.7 | 13.1 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.7 | 3.6 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.7 | 3.6 | GO:0097342 | ripoptosome(GO:0097342) |
0.7 | 10.9 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.7 | 5.1 | GO:0042581 | specific granule(GO:0042581) |
0.7 | 2.9 | GO:0033270 | paranode region of axon(GO:0033270) |
0.7 | 5.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.7 | 7.8 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.7 | 3.5 | GO:0031528 | microvillus membrane(GO:0031528) |
0.7 | 4.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.7 | 1.4 | GO:0005871 | kinesin complex(GO:0005871) |
0.7 | 2.1 | GO:0005745 | m-AAA complex(GO:0005745) |
0.7 | 28.6 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.7 | 1.4 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.7 | 0.7 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.7 | 6.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.7 | 5.5 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.7 | 6.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.7 | 4.8 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.7 | 3.4 | GO:0002141 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) |
0.7 | 34.0 | GO:0016605 | PML body(GO:0016605) |
0.7 | 4.8 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.7 | 6.8 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.7 | 1.4 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.7 | 27.7 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.7 | 2.0 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.7 | 8.7 | GO:0043034 | costamere(GO:0043034) |
0.7 | 0.7 | GO:1904949 | ATPase complex(GO:1904949) |
0.7 | 2.0 | GO:0038201 | TOR complex(GO:0038201) |
0.7 | 86.0 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.7 | 3.3 | GO:0001520 | outer dense fiber(GO:0001520) |
0.7 | 3.3 | GO:0061702 | inflammasome complex(GO:0061702) |
0.7 | 3.3 | GO:0008305 | integrin complex(GO:0008305) |
0.7 | 11.9 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.7 | 1.3 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.7 | 2.0 | GO:0000502 | proteasome complex(GO:0000502) |
0.7 | 3.3 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.7 | 5.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.7 | 1.3 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.6 | 0.6 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.6 | 3.8 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.6 | 1.9 | GO:0030914 | STAGA complex(GO:0030914) |
0.6 | 5.0 | GO:0031512 | motile primary cilium(GO:0031512) |
0.6 | 7.5 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.6 | 1.9 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.6 | 1.9 | GO:0016342 | catenin complex(GO:0016342) |
0.6 | 10.6 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.6 | 1.2 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.6 | 7.4 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.6 | 13.6 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.6 | 0.6 | GO:0043204 | perikaryon(GO:0043204) |
0.6 | 26.9 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.6 | 1.2 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.6 | 2.4 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.6 | 26.1 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.6 | 10.8 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.6 | 6.0 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.6 | 1.2 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.6 | 1.8 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.6 | 5.4 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.6 | 9.0 | GO:0043196 | varicosity(GO:0043196) |
0.6 | 23.9 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.6 | 11.3 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.6 | 4.2 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.6 | 1.2 | GO:1990923 | PET complex(GO:1990923) |
0.6 | 2.9 | GO:0034464 | BBSome(GO:0034464) |
0.6 | 1.8 | GO:0044194 | cytolytic granule(GO:0044194) |
0.6 | 6.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.6 | 1.8 | GO:0001650 | fibrillar center(GO:0001650) |
0.6 | 7.0 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.6 | 1.8 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.6 | 1.2 | GO:0031513 | nonmotile primary cilium(GO:0031513) |
0.6 | 3.5 | GO:0001891 | phagocytic cup(GO:0001891) |
0.6 | 4.7 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.6 | 1.7 | GO:1990423 | RZZ complex(GO:1990423) |
0.6 | 2.3 | GO:0035363 | histone locus body(GO:0035363) |
0.6 | 1.2 | GO:0043679 | axon terminus(GO:0043679) |
0.6 | 4.0 | GO:0070852 | cell body fiber(GO:0070852) |
0.6 | 0.6 | GO:0071817 | MMXD complex(GO:0071817) |
0.6 | 0.6 | GO:0060076 | excitatory synapse(GO:0060076) |
0.6 | 2.3 | GO:0061617 | MICOS complex(GO:0061617) |
0.6 | 3.4 | GO:0042587 | glycogen granule(GO:0042587) |
0.6 | 2.2 | GO:0031988 | membrane-bounded vesicle(GO:0031988) |
0.6 | 1.1 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.6 | 8.4 | GO:0005776 | autophagosome(GO:0005776) |
0.6 | 1.7 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.6 | 1.7 | GO:0001652 | granular component(GO:0001652) |
0.6 | 1.7 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.6 | 9.4 | GO:0031941 | filamentous actin(GO:0031941) |
0.6 | 20.4 | GO:0000139 | Golgi membrane(GO:0000139) |
0.5 | 4.9 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.5 | 15.4 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.5 | 11.5 | GO:0016235 | aggresome(GO:0016235) |
0.5 | 2.7 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.5 | 14.1 | GO:0031901 | early endosome membrane(GO:0031901) |
0.5 | 2.7 | GO:0034709 | methylosome(GO:0034709) |
0.5 | 9.7 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.5 | 8.0 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.5 | 3.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.5 | 9.1 | GO:0001772 | immunological synapse(GO:0001772) |
0.5 | 11.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.5 | 0.5 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.5 | 1.1 | GO:1990130 | Iml1 complex(GO:1990130) |
0.5 | 1.6 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.5 | 1.1 | GO:0005652 | nuclear lamina(GO:0005652) |
0.5 | 39.2 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.5 | 0.5 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.5 | 2.1 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.5 | 1.6 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.5 | 0.5 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.5 | 5.2 | GO:0000242 | pericentriolar material(GO:0000242) |
0.5 | 2.1 | GO:0032021 | NELF complex(GO:0032021) |
0.5 | 51.3 | GO:0005924 | cell-substrate adherens junction(GO:0005924) |
0.5 | 1.0 | GO:0098536 | deuterosome(GO:0098536) |
0.5 | 2.6 | GO:0097225 | sperm midpiece(GO:0097225) |
0.5 | 31.5 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.5 | 5.1 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.5 | 4.1 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.5 | 0.5 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.5 | 1.0 | GO:0032584 | growth cone membrane(GO:0032584) |
0.5 | 160.7 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.5 | 62.7 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.5 | 3.0 | GO:0031415 | NatA complex(GO:0031415) |
0.5 | 7.9 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.5 | 2.0 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.5 | 2.0 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.5 | 2.5 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.5 | 0.5 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.5 | 1.0 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.5 | 30.7 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.5 | 1.5 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.5 | 6.8 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.5 | 7.8 | GO:0005902 | microvillus(GO:0005902) |
0.5 | 0.5 | GO:0005688 | U6 snRNP(GO:0005688) |
0.5 | 8.2 | GO:0005657 | replication fork(GO:0005657) |
0.5 | 8.7 | GO:0032420 | stereocilium(GO:0032420) |
0.5 | 2.4 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.5 | 1.9 | GO:0002177 | manchette(GO:0002177) |
0.5 | 10.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.5 | 22.8 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) organelle envelope lumen(GO:0031970) |
0.5 | 17.5 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.5 | 0.9 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.5 | 0.9 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.5 | 9.4 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.5 | 1.9 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.5 | 786.4 | GO:0070062 | extracellular exosome(GO:0070062) |
0.5 | 36.4 | GO:0005938 | cell cortex(GO:0005938) |
0.5 | 0.9 | GO:0071547 | piP-body(GO:0071547) |
0.5 | 26.3 | GO:0005769 | early endosome(GO:0005769) |
0.5 | 3.2 | GO:0005861 | troponin complex(GO:0005861) |
0.5 | 5.9 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.5 | 0.5 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.4 | 8.0 | GO:0005840 | ribosome(GO:0005840) |
0.4 | 1.8 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.4 | 2.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.4 | 13.1 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.4 | 1.3 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.4 | 1.7 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.4 | 3.4 | GO:0008278 | cohesin complex(GO:0008278) |
0.4 | 1.7 | GO:0005682 | U5 snRNP(GO:0005682) |
0.4 | 0.4 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.4 | 0.8 | GO:1990635 | proximal dendrite(GO:1990635) |
0.4 | 0.4 | GO:0071953 | elastic fiber(GO:0071953) |
0.4 | 14.5 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.4 | 16.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.4 | 4.5 | GO:0071565 | nBAF complex(GO:0071565) |
0.4 | 10.2 | GO:0016592 | mediator complex(GO:0016592) |
0.4 | 0.4 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.4 | 309.1 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.4 | 0.8 | GO:0071439 | clathrin complex(GO:0071439) |
0.4 | 4.8 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.4 | 15.5 | GO:0043197 | dendritic spine(GO:0043197) |
0.4 | 50.3 | GO:0005667 | transcription factor complex(GO:0005667) |
0.4 | 110.4 | GO:0005730 | nucleolus(GO:0005730) |
0.4 | 1.6 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.4 | 7.1 | GO:0015030 | Cajal body(GO:0015030) |
0.4 | 1.6 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.4 | 0.8 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.4 | 1.9 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.4 | 4.6 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.4 | 14.4 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.4 | 1.5 | GO:0097546 | ciliary base(GO:0097546) |
0.4 | 365.4 | GO:0005654 | nucleoplasm(GO:0005654) |
0.4 | 3.7 | GO:0005813 | centrosome(GO:0005813) |
0.4 | 3.7 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.4 | 24.5 | GO:0005819 | spindle(GO:0005819) |
0.4 | 1.8 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.4 | 0.7 | GO:0090544 | BAF-type complex(GO:0090544) |
0.4 | 0.7 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.4 | 1.4 | GO:0031011 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.4 | 161.3 | GO:0005829 | cytosol(GO:0005829) |
0.4 | 1.1 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.3 | 5.5 | GO:0070069 | cytochrome complex(GO:0070069) |
0.3 | 2.1 | GO:0005874 | microtubule(GO:0005874) |
0.3 | 211.6 | GO:0005739 | mitochondrion(GO:0005739) |
0.3 | 1.7 | GO:0060170 | ciliary membrane(GO:0060170) |
0.3 | 2.0 | GO:0098562 | cytoplasmic side of membrane(GO:0098562) |
0.3 | 1.0 | GO:0000346 | transcription export complex(GO:0000346) |
0.3 | 0.7 | GO:0000802 | transverse filament(GO:0000802) |
0.3 | 0.3 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.3 | 0.3 | GO:0070938 | contractile ring(GO:0070938) |
0.3 | 0.9 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.3 | 11.4 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.3 | 4.9 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.3 | 0.6 | GO:0043195 | terminal bouton(GO:0043195) |
0.3 | 7.6 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.3 | 1.2 | GO:0000793 | condensed chromosome(GO:0000793) |
0.3 | 0.3 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.3 | 0.3 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.3 | 2.6 | GO:0030426 | growth cone(GO:0030426) |
0.3 | 656.0 | GO:0005737 | cytoplasm(GO:0005737) |
0.3 | 1.3 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 0.7 | GO:0005901 | caveola(GO:0005901) |
0.2 | 5.7 | GO:0031090 | organelle membrane(GO:0031090) |
0.2 | 3.4 | GO:0098552 | side of membrane(GO:0098552) |
0.2 | 222.0 | GO:0043231 | intracellular membrane-bounded organelle(GO:0043231) |
0.2 | 18.8 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.2 | 0.4 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.2 | 0.4 | GO:0043203 | axon hillock(GO:0043203) |
0.2 | 4.4 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 73.2 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 0.4 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 54.0 | GO:0005576 | extracellular region(GO:0005576) |
0.1 | 26.9 | GO:0005622 | intracellular(GO:0005622) |
0.1 | 347.4 | GO:0016021 | integral component of membrane(GO:0016021) |
0.1 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.5 | GO:0009986 | cell surface(GO:0009986) |
0.0 | 0.0 | GO:0098797 | plasma membrane protein complex(GO:0098797) |
0.0 | 4.9 | GO:0016020 | membrane(GO:0016020) |
0.0 | 0.3 | GO:0032991 | macromolecular complex(GO:0032991) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.1 | 33.2 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
7.1 | 21.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
5.5 | 22.2 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
4.2 | 16.7 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
3.9 | 11.6 | GO:0035877 | death effector domain binding(GO:0035877) |
3.8 | 30.6 | GO:0008430 | selenium binding(GO:0008430) |
3.8 | 11.4 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
3.8 | 11.3 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
3.8 | 11.3 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
3.7 | 11.0 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
3.7 | 14.6 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
3.5 | 10.6 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
3.3 | 16.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
3.0 | 9.1 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
3.0 | 18.3 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
3.0 | 11.8 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
2.9 | 11.8 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
2.9 | 8.8 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
2.9 | 20.4 | GO:0050897 | cobalt ion binding(GO:0050897) |
2.9 | 14.6 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
2.9 | 11.6 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
2.9 | 11.6 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
2.8 | 8.5 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
2.8 | 2.8 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
2.8 | 8.4 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
2.8 | 8.3 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
2.7 | 59.9 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
2.7 | 2.7 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
2.7 | 8.1 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
2.7 | 18.8 | GO:0050700 | CARD domain binding(GO:0050700) |
2.6 | 7.9 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
2.6 | 10.4 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
2.6 | 2.6 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
2.6 | 12.8 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
2.6 | 10.2 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
2.5 | 9.9 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
2.5 | 7.4 | GO:0043199 | sulfate binding(GO:0043199) |
2.4 | 12.2 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
2.4 | 7.3 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
2.3 | 9.4 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
2.3 | 25.8 | GO:0070700 | BMP receptor binding(GO:0070700) |
2.3 | 11.7 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
2.3 | 6.9 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
2.3 | 6.8 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
2.3 | 6.8 | GO:0017166 | vinculin binding(GO:0017166) |
2.3 | 6.8 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
2.2 | 6.7 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
2.2 | 6.7 | GO:0030274 | LIM domain binding(GO:0030274) |
2.2 | 15.5 | GO:0046790 | virion binding(GO:0046790) |
2.2 | 11.0 | GO:0038132 | neuregulin binding(GO:0038132) |
2.2 | 17.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
2.1 | 10.7 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
2.1 | 6.4 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
2.1 | 6.4 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
2.1 | 4.3 | GO:0042609 | CD4 receptor binding(GO:0042609) |
2.1 | 6.4 | GO:0070644 | vitamin D response element binding(GO:0070644) |
2.1 | 6.4 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
2.1 | 14.9 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
2.1 | 6.4 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
2.1 | 12.7 | GO:0033265 | choline binding(GO:0033265) |
2.1 | 10.5 | GO:0030515 | snoRNA binding(GO:0030515) |
2.1 | 8.3 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
2.1 | 26.8 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
2.1 | 4.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
2.0 | 53.2 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
2.0 | 6.1 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
2.0 | 12.1 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
2.0 | 6.0 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
2.0 | 6.0 | GO:0030621 | U4 snRNA binding(GO:0030621) |
2.0 | 7.9 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
2.0 | 7.9 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
2.0 | 7.8 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
2.0 | 9.8 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
1.9 | 21.0 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
1.9 | 19.1 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
1.9 | 62.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
1.9 | 7.6 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
1.9 | 9.5 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
1.9 | 17.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
1.8 | 7.3 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
1.8 | 5.5 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
1.8 | 5.5 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
1.8 | 7.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
1.8 | 5.4 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
1.8 | 12.7 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
1.8 | 5.4 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
1.8 | 5.4 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
1.8 | 5.4 | GO:1990188 | euchromatin binding(GO:1990188) |
1.8 | 8.9 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
1.8 | 7.1 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
1.8 | 7.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.7 | 6.9 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
1.7 | 5.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
1.7 | 5.2 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
1.7 | 6.8 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
1.7 | 15.3 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
1.7 | 3.4 | GO:0055100 | adiponectin binding(GO:0055100) |
1.7 | 25.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
1.7 | 6.7 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
1.7 | 15.1 | GO:0042301 | phosphate ion binding(GO:0042301) |
1.7 | 5.0 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
1.7 | 6.7 | GO:0004046 | aminoacylase activity(GO:0004046) |
1.7 | 1.7 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
1.7 | 5.0 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
1.6 | 1.6 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
1.6 | 3.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
1.6 | 21.3 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
1.6 | 1.6 | GO:0016429 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
1.6 | 6.5 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
1.6 | 6.5 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
1.6 | 4.9 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
1.6 | 3.3 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
1.6 | 4.8 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
1.6 | 9.7 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
1.6 | 1.6 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
1.6 | 4.8 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
1.6 | 1.6 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
1.6 | 3.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
1.6 | 3.2 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
1.6 | 7.8 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
1.6 | 1.6 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
1.6 | 51.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
1.6 | 10.9 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
1.6 | 14.0 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
1.6 | 15.5 | GO:0051400 | BH domain binding(GO:0051400) |
1.6 | 3.1 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
1.5 | 6.2 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
1.5 | 4.6 | GO:0005119 | smoothened binding(GO:0005119) |
1.5 | 7.6 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
1.5 | 6.0 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
1.5 | 3.0 | GO:0032052 | bile acid binding(GO:0032052) |
1.5 | 10.5 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
1.5 | 9.0 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
1.5 | 13.5 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
1.5 | 4.5 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
1.5 | 4.5 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
1.5 | 17.8 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
1.5 | 11.8 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
1.5 | 7.4 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
1.5 | 4.4 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
1.5 | 7.4 | GO:1990239 | steroid hormone binding(GO:1990239) |
1.5 | 7.3 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
1.5 | 14.5 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
1.5 | 4.4 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
1.4 | 1.4 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
1.4 | 4.3 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.4 | 14.4 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
1.4 | 14.4 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
1.4 | 4.3 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
1.4 | 11.4 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
1.4 | 5.7 | GO:1990715 | mRNA CDS binding(GO:1990715) |
1.4 | 1.4 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
1.4 | 5.6 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
1.4 | 4.2 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
1.4 | 15.4 | GO:0044548 | S100 protein binding(GO:0044548) |
1.4 | 2.8 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.4 | 5.6 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
1.4 | 5.6 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
1.4 | 5.5 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
1.4 | 2.7 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
1.4 | 5.5 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
1.4 | 20.4 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
1.4 | 4.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
1.4 | 2.7 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
1.3 | 6.7 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
1.3 | 9.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
1.3 | 5.3 | GO:0042015 | interleukin-20 binding(GO:0042015) |
1.3 | 4.0 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
1.3 | 5.3 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
1.3 | 10.6 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
1.3 | 3.9 | GO:0045340 | mercury ion binding(GO:0045340) |
1.3 | 5.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
1.3 | 3.9 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
1.3 | 2.6 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
1.3 | 6.5 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
1.3 | 38.7 | GO:0015485 | cholesterol binding(GO:0015485) |
1.3 | 5.2 | GO:0017040 | ceramidase activity(GO:0017040) |
1.3 | 19.3 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
1.3 | 6.4 | GO:0030151 | molybdenum ion binding(GO:0030151) |
1.3 | 7.7 | GO:0015288 | porin activity(GO:0015288) |
1.3 | 15.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
1.3 | 3.8 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
1.3 | 1.3 | GO:0043559 | insulin binding(GO:0043559) |
1.2 | 3.7 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
1.2 | 2.5 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
1.2 | 3.7 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
1.2 | 1.2 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
1.2 | 6.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
1.2 | 8.6 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
1.2 | 4.9 | GO:0070324 | thyroid hormone binding(GO:0070324) |
1.2 | 2.5 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
1.2 | 7.3 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
1.2 | 4.8 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
1.2 | 7.2 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
1.2 | 3.6 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
1.2 | 11.9 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
1.2 | 2.4 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
1.2 | 38.1 | GO:0035591 | signaling adaptor activity(GO:0035591) |
1.2 | 3.6 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
1.2 | 3.6 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
1.2 | 3.6 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
1.2 | 4.7 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
1.2 | 9.4 | GO:0034951 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
1.2 | 3.5 | GO:0030984 | kininogen binding(GO:0030984) |
1.2 | 2.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
1.2 | 18.7 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
1.2 | 27.9 | GO:0001221 | transcription cofactor binding(GO:0001221) |
1.2 | 2.3 | GO:0002060 | purine nucleobase binding(GO:0002060) |
1.2 | 7.0 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
1.2 | 2.3 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
1.2 | 5.8 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
1.2 | 3.5 | GO:0016842 | amidine-lyase activity(GO:0016842) |
1.2 | 8.1 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
1.2 | 24.3 | GO:0045296 | cadherin binding(GO:0045296) |
1.2 | 1.2 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
1.1 | 11.5 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
1.1 | 4.6 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
1.1 | 12.6 | GO:0003785 | actin monomer binding(GO:0003785) |
1.1 | 19.4 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
1.1 | 3.4 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
1.1 | 6.8 | GO:0001727 | lipid kinase activity(GO:0001727) |
1.1 | 4.5 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
1.1 | 17.0 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
1.1 | 2.3 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
1.1 | 3.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
1.1 | 5.6 | GO:0005346 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
1.1 | 4.5 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
1.1 | 1.1 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
1.1 | 5.6 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
1.1 | 3.3 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
1.1 | 18.8 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
1.1 | 2.2 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
1.1 | 3.3 | GO:0031685 | adenosine receptor binding(GO:0031685) |
1.1 | 9.9 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
1.1 | 1.1 | GO:0034618 | arginine binding(GO:0034618) |
1.1 | 7.7 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
1.1 | 5.5 | GO:0070403 | NAD+ binding(GO:0070403) |
1.1 | 4.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
1.1 | 21.9 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
1.1 | 14.2 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
1.1 | 1.1 | GO:0070061 | fructose binding(GO:0070061) |
1.1 | 5.4 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
1.1 | 5.4 | GO:0034046 | poly(G) binding(GO:0034046) |
1.1 | 5.4 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
1.1 | 3.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.1 | 4.3 | GO:0050544 | icosanoid binding(GO:0050542) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
1.1 | 2.2 | GO:0070905 | serine binding(GO:0070905) |
1.1 | 14.0 | GO:0008143 | poly(A) binding(GO:0008143) |
1.1 | 9.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
1.1 | 1.1 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
1.1 | 9.7 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
1.1 | 19.3 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
1.1 | 26.7 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
1.1 | 7.5 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
1.1 | 3.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
1.1 | 30.7 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
1.1 | 3.2 | GO:0016936 | galactoside binding(GO:0016936) |
1.1 | 4.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
1.1 | 6.3 | GO:0016208 | AMP binding(GO:0016208) |
1.1 | 9.5 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
1.0 | 7.3 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
1.0 | 29.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
1.0 | 3.1 | GO:0019961 | interferon binding(GO:0019961) |
1.0 | 4.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
1.0 | 19.7 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
1.0 | 10.4 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
1.0 | 5.2 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
1.0 | 8.3 | GO:0010181 | FMN binding(GO:0010181) |
1.0 | 6.2 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
1.0 | 3.1 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
1.0 | 3.1 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
1.0 | 3.1 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
1.0 | 21.6 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
1.0 | 8.2 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
1.0 | 1.0 | GO:0033142 | progesterone receptor binding(GO:0033142) |
1.0 | 1.0 | GO:0000405 | bubble DNA binding(GO:0000405) |
1.0 | 1.0 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
1.0 | 3.1 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
1.0 | 28.5 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
1.0 | 4.0 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
1.0 | 7.1 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
1.0 | 5.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
1.0 | 7.1 | GO:0034871 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
1.0 | 8.1 | GO:1990446 | U1 snRNP binding(GO:1990446) |
1.0 | 1.0 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
1.0 | 2.0 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
1.0 | 11.1 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
1.0 | 8.0 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
1.0 | 5.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
1.0 | 7.0 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
1.0 | 9.9 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
1.0 | 14.9 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
1.0 | 14.9 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
1.0 | 36.5 | GO:0005044 | scavenger receptor activity(GO:0005044) |
1.0 | 1.0 | GO:0010851 | cyclase regulator activity(GO:0010851) |
1.0 | 3.0 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
1.0 | 7.8 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
1.0 | 8.8 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
1.0 | 11.7 | GO:0034185 | apolipoprotein binding(GO:0034185) |
1.0 | 9.7 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
1.0 | 3.9 | GO:0070878 | primary miRNA binding(GO:0070878) |
1.0 | 3.9 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
1.0 | 3.9 | GO:0031013 | troponin I binding(GO:0031013) |
1.0 | 2.9 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
1.0 | 10.6 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
1.0 | 2.9 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
1.0 | 2.9 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
1.0 | 6.7 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
1.0 | 3.8 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
1.0 | 3.8 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
1.0 | 2.9 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
1.0 | 13.4 | GO:0001671 | ATPase activator activity(GO:0001671) |
1.0 | 2.9 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
1.0 | 5.7 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
1.0 | 11.4 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
1.0 | 2.9 | GO:0019862 | IgA binding(GO:0019862) |
0.9 | 0.9 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.9 | 0.9 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.9 | 8.5 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.9 | 12.2 | GO:0018748 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
0.9 | 3.7 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.9 | 8.4 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.9 | 10.2 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.9 | 7.4 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.9 | 0.9 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.9 | 13.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.9 | 0.9 | GO:0071253 | connexin binding(GO:0071253) |
0.9 | 4.6 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.9 | 3.6 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.9 | 1.8 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.9 | 3.6 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.9 | 2.7 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.9 | 9.0 | GO:0015665 | polyol transmembrane transporter activity(GO:0015166) alcohol transmembrane transporter activity(GO:0015665) |
0.9 | 9.0 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.9 | 3.6 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.9 | 16.2 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.9 | 0.9 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.9 | 6.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.9 | 3.6 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.9 | 7.2 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.9 | 2.7 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.9 | 12.5 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.9 | 6.3 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.9 | 1.8 | GO:0004103 | choline kinase activity(GO:0004103) |
0.9 | 3.6 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.9 | 1.8 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.9 | 3.6 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.9 | 3.5 | GO:0042731 | PH domain binding(GO:0042731) |
0.9 | 7.1 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.9 | 1.8 | GO:0017065 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.9 | 73.0 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.9 | 1.8 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.9 | 63.1 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.9 | 1.7 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.9 | 7.9 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.9 | 87.0 | GO:0051015 | actin filament binding(GO:0051015) |
0.9 | 6.9 | GO:0051766 | inositol trisphosphate kinase activity(GO:0051766) |
0.9 | 4.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.9 | 1.7 | GO:0002054 | nucleobase binding(GO:0002054) |
0.9 | 2.6 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.9 | 2.6 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.9 | 6.9 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.9 | 2.6 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.9 | 4.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.8 | 2.5 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.8 | 11.0 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.8 | 12.7 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.8 | 3.4 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.8 | 1.7 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.8 | 3.3 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.8 | 10.8 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.8 | 3.3 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.8 | 14.2 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.8 | 2.5 | GO:0052742 | phosphatidylinositol kinase activity(GO:0052742) |
0.8 | 2.5 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.8 | 4.1 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.8 | 1.6 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.8 | 1.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.8 | 2.5 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.8 | 0.8 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.8 | 1.6 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.8 | 4.9 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.8 | 9.0 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.8 | 4.9 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.8 | 4.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.8 | 12.2 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.8 | 2.4 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.8 | 5.6 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.8 | 6.4 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.8 | 1.6 | GO:0008194 | UDP-glycosyltransferase activity(GO:0008194) |
0.8 | 7.2 | GO:0005521 | lamin binding(GO:0005521) |
0.8 | 8.8 | GO:0036222 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
0.8 | 1.6 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.8 | 7.2 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.8 | 5.5 | GO:0018636 | phenanthrene 9,10-monooxygenase activity(GO:0018636) |
0.8 | 5.5 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.8 | 3.9 | GO:0005113 | patched binding(GO:0005113) |
0.8 | 1.6 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.8 | 7.0 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.8 | 77.1 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.8 | 7.8 | GO:0034946 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.8 | 3.1 | GO:0043426 | MRF binding(GO:0043426) |
0.8 | 3.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.8 | 1.6 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.8 | 6.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.8 | 9.2 | GO:0016918 | retinal binding(GO:0016918) |
0.8 | 1.5 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.8 | 2.3 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.8 | 6.9 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.8 | 1.5 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.8 | 3.8 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
0.8 | 0.8 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.8 | 4.5 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.8 | 2.3 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.8 | 2.3 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.7 | 5.2 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.7 | 17.9 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.7 | 2.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.7 | 3.7 | GO:0000150 | recombinase activity(GO:0000150) |
0.7 | 0.7 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.7 | 0.7 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.7 | 19.9 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.7 | 29.1 | GO:0060090 | binding, bridging(GO:0060090) |
0.7 | 1.5 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.7 | 16.0 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.7 | 7.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.7 | 2.9 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.7 | 2.2 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.7 | 2.9 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.7 | 1.4 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.7 | 13.6 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.7 | 0.7 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.7 | 3.6 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.7 | 20.7 | GO:0005507 | copper ion binding(GO:0005507) |
0.7 | 2.1 | GO:0019002 | GMP binding(GO:0019002) |
0.7 | 7.8 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.7 | 1.4 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.7 | 11.3 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.7 | 0.7 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.7 | 3.5 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.7 | 5.6 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.7 | 2.8 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.7 | 1.4 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.7 | 3.5 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.7 | 4.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.7 | 3.4 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.7 | 0.7 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.7 | 2.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.7 | 3.4 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.7 | 2.0 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.7 | 10.1 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.7 | 7.4 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.7 | 6.7 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.7 | 2.7 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.7 | 1.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.7 | 4.0 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.7 | 17.3 | GO:0050253 | prenylcysteine methylesterase activity(GO:0010296) 1-oxa-2-oxocycloheptane lactonase activity(GO:0018731) sulfolactone hydrolase activity(GO:0018732) 3,4-dihydrocoumarin hydrolase activity(GO:0018733) butyrolactone hydrolase activity(GO:0018734) endosulfan lactone lactonase activity(GO:0034892) L-ascorbate 6-phosphate lactonase activity(GO:0035460) Ser-tRNA(Thr) hydrolase activity(GO:0043905) Ala-tRNA(Pro) hydrolase activity(GO:0043906) Cys-tRNA(Pro) hydrolase activity(GO:0043907) Ser(Gly)-tRNA(Ala) hydrolase activity(GO:0043908) all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity(GO:0047376) retinyl-palmitate esterase activity(GO:0050253) mannosyl-oligosaccharide 1,6-alpha-mannosidase activity(GO:0052767) mannosyl-oligosaccharide 1,3-alpha-mannosidase activity(GO:0052768) methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.7 | 119.0 | GO:0043773 | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligase activity(GO:0008766) ribosomal S6-glutamic acid ligase activity(GO:0018169) coenzyme F420-0 gamma-glutamyl ligase activity(GO:0043773) coenzyme F420-2 alpha-glutamyl ligase activity(GO:0043774) protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) protein-glycine ligase activity, elongating(GO:0070737) tubulin-glycine ligase activity(GO:0070738) |
0.7 | 0.7 | GO:0070990 | snRNP binding(GO:0070990) |
0.7 | 0.7 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.7 | 11.9 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.7 | 7.3 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.7 | 6.6 | GO:0019213 | deacetylase activity(GO:0019213) |
0.7 | 2.6 | GO:0052796 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.7 | 5.9 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.7 | 4.6 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.7 | 3.3 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.7 | 14.4 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.7 | 0.7 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.7 | 7.8 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.7 | 2.6 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.7 | 2.6 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.7 | 3.3 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.7 | 13.0 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.7 | 102.2 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.6 | 1.9 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.6 | 1.9 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.6 | 3.2 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.6 | 24.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.6 | 0.6 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.6 | 0.6 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.6 | 2.6 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.6 | 1.9 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.6 | 1.9 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.6 | 1.9 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.6 | 0.6 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.6 | 1.9 | GO:0005534 | galactose binding(GO:0005534) |
0.6 | 1.3 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.6 | 2.5 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.6 | 2.5 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.6 | 4.4 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.6 | 1.9 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.6 | 0.6 | GO:0004096 | catalase activity(GO:0004096) |
0.6 | 2.5 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.6 | 0.6 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.6 | 0.6 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.6 | 1.2 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.6 | 1.2 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.6 | 4.3 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.6 | 3.7 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.6 | 11.0 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.6 | 1.8 | GO:0043515 | kinetochore binding(GO:0043515) |
0.6 | 2.4 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.6 | 1.8 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.6 | 4.3 | GO:0003796 | lysozyme activity(GO:0003796) |
0.6 | 2.4 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
0.6 | 12.1 | GO:0015928 | fucosidase activity(GO:0015928) |
0.6 | 15.1 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.6 | 5.4 | GO:0043274 | phospholipase binding(GO:0043274) |
0.6 | 18.1 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.6 | 0.6 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.6 | 0.6 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.6 | 3.0 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.6 | 7.8 | GO:0022840 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.6 | 3.0 | GO:0031419 | cobalamin binding(GO:0031419) |
0.6 | 1.8 | GO:0038100 | nodal binding(GO:0038100) |
0.6 | 1.2 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.6 | 24.4 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.6 | 0.6 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.6 | 4.8 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.6 | 2.9 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.6 | 5.9 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.6 | 9.4 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.6 | 1.2 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.6 | 2.3 | GO:0030957 | Tat protein binding(GO:0030957) |
0.6 | 2.9 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.6 | 1.8 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.6 | 1.8 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.6 | 4.7 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.6 | 2.9 | GO:0043830 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.6 | 1.7 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.6 | 0.6 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.6 | 2.3 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.6 | 0.6 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.6 | 1.2 | GO:0008199 | ferric iron binding(GO:0008199) |
0.6 | 10.9 | GO:0043236 | laminin binding(GO:0043236) |
0.6 | 13.8 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.6 | 3.4 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.6 | 1.7 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.6 | 1.1 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.6 | 4.0 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.6 | 1.7 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.6 | 1.7 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.6 | 1.1 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.6 | 7.9 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.6 | 7.3 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.6 | 1.1 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.6 | 5.0 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.6 | 3.9 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.6 | 0.6 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.6 | 1.7 | GO:0034452 | dynactin binding(GO:0034452) |
0.6 | 0.6 | GO:0016419 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.6 | 5.5 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.6 | 2.8 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.6 | 1.1 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.5 | 2.7 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.5 | 6.6 | GO:0015643 | toxic substance binding(GO:0015643) |
0.5 | 7.1 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.5 | 16.9 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.5 | 1.1 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.5 | 0.5 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.5 | 26.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.5 | 1.6 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.5 | 50.8 | GO:0042393 | histone binding(GO:0042393) |
0.5 | 0.5 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.5 | 1.6 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.5 | 2.1 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.5 | 5.9 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.5 | 5.3 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.5 | 0.5 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.5 | 4.7 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.5 | 1.0 | GO:0030519 | snoRNP binding(GO:0030519) |
0.5 | 1.6 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.5 | 3.7 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.5 | 0.5 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.5 | 2.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.5 | 3.1 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.5 | 1.0 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.5 | 5.7 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.5 | 1.5 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.5 | 3.1 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.5 | 0.5 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.5 | 5.6 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.5 | 2.0 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.5 | 2.0 | GO:0035198 | miRNA binding(GO:0035198) |
0.5 | 0.5 | GO:0072349 | thyroid hormone transmembrane transporter activity(GO:0015349) modified amino acid transmembrane transporter activity(GO:0072349) |
0.5 | 3.5 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.5 | 31.2 | GO:0005178 | integrin binding(GO:0005178) |
0.5 | 11.6 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.5 | 7.5 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.5 | 3.5 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.5 | 46.9 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.5 | 0.5 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.5 | 1.0 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.5 | 1.0 | GO:0051870 | methotrexate binding(GO:0051870) |
0.5 | 1.0 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.5 | 1.5 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.5 | 1.0 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.5 | 4.4 | GO:0002039 | p53 binding(GO:0002039) |
0.5 | 0.5 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.5 | 1.0 | GO:0097016 | L27 domain binding(GO:0097016) |
0.5 | 1.4 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.5 | 13.0 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
0.5 | 1.4 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.5 | 1.4 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.5 | 0.5 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.5 | 2.4 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.5 | 1.9 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.5 | 5.6 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.5 | 3.3 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.5 | 1.9 | GO:0045545 | syndecan binding(GO:0045545) |
0.5 | 0.9 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.5 | 1.4 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.5 | 7.4 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.5 | 2.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.5 | 5.5 | GO:0015026 | coreceptor activity(GO:0015026) |
0.5 | 0.9 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.5 | 1.4 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.5 | 0.9 | GO:0001846 | opsonin binding(GO:0001846) |
0.5 | 1.8 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.5 | 3.6 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.5 | 0.9 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.5 | 0.5 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
0.4 | 2.2 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.4 | 1.8 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.4 | 4.4 | GO:0001618 | virus receptor activity(GO:0001618) |
0.4 | 33.8 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.4 | 1.3 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.4 | 3.5 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.4 | 0.4 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.4 | 0.9 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.4 | 3.1 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.4 | 1.8 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.4 | 2.2 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.4 | 1.3 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.4 | 2.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.4 | 1.3 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.4 | 0.4 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.4 | 9.0 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.4 | 3.4 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.4 | 1.7 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.4 | 5.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.4 | 14.0 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.4 | 98.6 | GO:0005525 | GTP binding(GO:0005525) |
0.4 | 0.4 | GO:0019808 | polyamine binding(GO:0019808) |
0.4 | 0.4 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.4 | 1.7 | GO:0015925 | galactosidase activity(GO:0015925) |
0.4 | 1.7 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.4 | 0.4 | GO:0015926 | glucosidase activity(GO:0015926) |
0.4 | 10.9 | GO:0001047 | core promoter binding(GO:0001047) |
0.4 | 83.5 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.4 | 56.9 | GO:0008134 | transcription factor binding(GO:0008134) |
0.4 | 0.4 | GO:0031432 | titin binding(GO:0031432) |
0.4 | 0.8 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.4 | 3.3 | GO:0031491 | nucleosome binding(GO:0031491) |
0.4 | 25.6 | GO:0035326 | enhancer binding(GO:0035326) |
0.4 | 2.1 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.4 | 0.8 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.4 | 11.1 | GO:0008907 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.4 | 0.8 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.4 | 2.0 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.4 | 9.8 | GO:0016876 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.4 | 2.4 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.4 | 8.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.4 | 9.3 | GO:0043734 | DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.4 | 8.5 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.4 | 0.8 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.4 | 5.6 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.4 | 0.8 | GO:0050733 | RS domain binding(GO:0050733) |
0.4 | 5.6 | GO:0051119 | sugar transmembrane transporter activity(GO:0051119) |
0.4 | 2.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.4 | 0.4 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.4 | 7.9 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.4 | 1.2 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.4 | 4.3 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.4 | 1.2 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.4 | 5.1 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.4 | 1.6 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.4 | 0.4 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.4 | 0.8 | GO:0034584 | piRNA binding(GO:0034584) |
0.4 | 0.4 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.4 | 7.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.4 | 1.1 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.4 | 4.6 | GO:0030552 | cAMP binding(GO:0030552) |
0.4 | 2.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.4 | 2.6 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.4 | 0.8 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.4 | 1.9 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.4 | 10.9 | GO:0070330 | aromatase activity(GO:0070330) |
0.4 | 1.1 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.4 | 7.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.4 | 1.1 | GO:0048038 | quinone binding(GO:0048038) |
0.4 | 0.7 | GO:0070728 | leucine binding(GO:0070728) |
0.4 | 2.2 | GO:0030553 | cGMP binding(GO:0030553) |
0.4 | 1.1 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.4 | 1.5 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.4 | 0.4 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.4 | 0.4 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.4 | 9.2 | GO:0050699 | WW domain binding(GO:0050699) |
0.4 | 7.0 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.4 | 0.7 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.4 | 0.4 | GO:0016414 | O-octanoyltransferase activity(GO:0016414) |
0.4 | 5.4 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
0.4 | 2.2 | GO:0046332 | SMAD binding(GO:0046332) |
0.4 | 1.1 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.4 | 2.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.4 | 37.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.4 | 1.1 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.4 | 1.4 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.4 | 1.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.4 | 0.4 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.4 | 0.4 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.4 | 9.2 | GO:0000049 | tRNA binding(GO:0000049) |
0.4 | 1.4 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.4 | 1.4 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.3 | 5.6 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.3 | 2.1 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.3 | 1.0 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.3 | 1.0 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.3 | 0.7 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.3 | 9.2 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.3 | 0.3 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.3 | 0.7 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.3 | 3.0 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.3 | 1.0 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.3 | 55.6 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.3 | 0.7 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.3 | 1.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.3 | 6.3 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.3 | 0.7 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.3 | 0.3 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.3 | 1.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.3 | 0.3 | GO:0048156 | tau protein binding(GO:0048156) |
0.3 | 0.6 | GO:0000182 | rDNA binding(GO:0000182) |
0.3 | 0.3 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.3 | 0.6 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.3 | 1.9 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.3 | 1.0 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.3 | 1.9 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.3 | 0.6 | GO:0000339 | RNA cap binding(GO:0000339) |
0.3 | 0.9 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.3 | 1.3 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.3 | 0.6 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.3 | 7.4 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.3 | 1.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.3 | 18.7 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.3 | 5.2 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.3 | 2.7 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.3 | 2.6 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.3 | 0.6 | GO:0015556 | L-aspartate transmembrane transporter activity(GO:0015183) C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.3 | 4.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.3 | 2.3 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.3 | 1.8 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.3 | 0.3 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.3 | 0.6 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.3 | 0.3 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.3 | 1.7 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.3 | 0.3 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.3 | 107.7 | GO:0005198 | structural molecule activity(GO:0005198) |
0.3 | 0.8 | GO:0052744 | phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
0.3 | 2.0 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.3 | 1.4 | GO:0039706 | co-receptor binding(GO:0039706) |
0.3 | 0.6 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.3 | 206.8 | GO:0003677 | DNA binding(GO:0003677) |
0.3 | 5.3 | GO:0030276 | clathrin binding(GO:0030276) |
0.3 | 0.8 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.3 | 0.8 | GO:0009374 | biotin binding(GO:0009374) |
0.3 | 10.1 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.3 | 0.5 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.3 | 0.3 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.3 | 2.1 | GO:0043022 | ribosome binding(GO:0043022) |
0.3 | 13.3 | GO:0004386 | helicase activity(GO:0004386) |
0.3 | 1.8 | GO:0004568 | chitinase activity(GO:0004568) |
0.3 | 9.9 | GO:0008527 | taste receptor activity(GO:0008527) |
0.3 | 13.6 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.3 | 3.9 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.3 | 0.8 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.3 | 8.5 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.3 | 2.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.3 | 0.8 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.3 | 0.8 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.3 | 2.0 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.3 | 0.8 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.3 | 0.3 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.3 | 15.4 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.3 | 2.5 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.3 | 1.0 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.3 | 42.7 | GO:0019900 | kinase binding(GO:0019900) |
0.3 | 0.5 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.3 | 1.0 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.3 | 1.0 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.3 | 0.3 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.3 | 4.5 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.2 | 0.2 | GO:0008061 | chitin binding(GO:0008061) |
0.2 | 0.7 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.2 | 0.5 | GO:0005536 | glucose binding(GO:0005536) |
0.2 | 1.0 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.2 | 0.7 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.2 | 2.5 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 17.2 | GO:0003774 | motor activity(GO:0003774) |
0.2 | 15.9 | GO:0000989 | transcription factor activity, transcription factor binding(GO:0000989) |
0.2 | 37.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.2 | 0.5 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.2 | 0.2 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.2 | 0.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.2 | 0.2 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.2 | 0.7 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.2 | 1.8 | GO:0045502 | dynein binding(GO:0045502) |
0.2 | 1.1 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.2 | 1.6 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.2 | 0.4 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.2 | 2.4 | GO:0015179 | L-amino acid transmembrane transporter activity(GO:0015179) |
0.2 | 2.4 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.2 | 98.1 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.2 | 4.1 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.2 | 9.9 | GO:0044389 | ubiquitin-like protein ligase binding(GO:0044389) |
0.2 | 6.9 | GO:0000149 | SNARE binding(GO:0000149) |
0.2 | 0.6 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.2 | 3.1 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.2 | 0.4 | GO:0035258 | steroid hormone receptor binding(GO:0035258) |
0.2 | 0.2 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.2 | 4.0 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.2 | 0.6 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.2 | 1.4 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.2 | 0.8 | GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors(GO:0016614) |
0.2 | 0.8 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 0.2 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.2 | 0.9 | GO:0036122 | BMP binding(GO:0036122) |
0.2 | 0.6 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.2 | 0.4 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.2 | 0.4 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.2 | 0.4 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 1.4 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.2 | 0.5 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.2 | 0.5 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
0.2 | 0.3 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.2 | 0.2 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.2 | 6.0 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.2 | 1.2 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.2 | 16.8 | GO:0003779 | actin binding(GO:0003779) |
0.2 | 0.7 | GO:0030332 | cyclin binding(GO:0030332) |
0.2 | 2.4 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.2 | 0.6 | GO:0051287 | NAD binding(GO:0051287) |
0.2 | 0.3 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.2 | 0.9 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.2 | 1.4 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.2 | 2.6 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.2 | 17.3 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.2 | 0.5 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.2 | 0.2 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.2 | 5.5 | GO:0019887 | protein kinase regulator activity(GO:0019887) |
0.2 | 26.0 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.1 | 0.1 | GO:0035004 | phosphatidylinositol 3-kinase activity(GO:0035004) |
0.1 | 0.7 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 5.0 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 0.3 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.1 | 0.3 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.1 | 1.0 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 18.8 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.1 | 0.4 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.1 | 0.4 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.1 | 1.2 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.1 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.1 | 0.1 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.1 | 8.0 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.1 | 0.8 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.1 | 4.2 | GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0016616) |
0.1 | 25.8 | GO:0008270 | zinc ion binding(GO:0008270) |
0.1 | 10.8 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 0.2 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.1 | 1.8 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.2 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.1 | 0.6 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.2 | GO:0098631 | protein binding involved in cell adhesion(GO:0098631) |
0.1 | 1.6 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.1 | 0.4 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 0.1 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 0.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.2 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 10.9 | GO:0016758 | transferase activity, transferring hexosyl groups(GO:0016758) |
0.1 | 0.1 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.1 | 0.2 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.1 | 0.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.5 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.1 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.1 | 6.7 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 0.4 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.1 | 2.1 | GO:0005496 | steroid binding(GO:0005496) |
0.1 | 0.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.3 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.1 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.1 | 0.5 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 0.1 | GO:0051379 | alpha2-adrenergic receptor activity(GO:0004938) epinephrine binding(GO:0051379) |
0.1 | 0.1 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 0.7 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.1 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 0.2 | GO:0051861 | glycolipid binding(GO:0051861) |
0.1 | 0.7 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.1 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.2 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.1 | 0.1 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.1 | 0.2 | GO:0016722 | oxidoreductase activity, oxidizing metal ions(GO:0016722) |
0.1 | 0.4 | GO:0016594 | glycine binding(GO:0016594) |
0.1 | 0.1 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.1 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.1 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.2 | GO:2001069 | glycogen binding(GO:2001069) |
0.0 | 0.7 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 4.2 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.4 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 1.0 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.0 | GO:0070052 | collagen V binding(GO:0070052) |
0.0 | 0.0 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.0 | 1.1 | GO:0015293 | symporter activity(GO:0015293) |
0.0 | 0.5 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 0.1 | GO:0048185 | activin binding(GO:0048185) |
0.0 | 0.5 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.7 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 1.0 | GO:0046906 | heme binding(GO:0020037) tetrapyrrole binding(GO:0046906) |
0.0 | 0.1 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 0.5 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.0 | 0.0 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.0 | 0.0 | GO:0023023 | MHC protein complex binding(GO:0023023) |
0.0 | 0.3 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.3 | GO:0005319 | lipid transporter activity(GO:0005319) |
0.0 | 5.8 | GO:0042802 | identical protein binding(GO:0042802) |
0.0 | 3.1 | GO:0005102 | receptor binding(GO:0005102) |
0.0 | 0.2 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.4 | GO:0001664 | G-protein coupled receptor binding(GO:0001664) |
0.0 | 0.1 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.0 | 0.5 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.0 | 17.1 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.6 | GO:0019902 | phosphatase binding(GO:0019902) |
0.0 | 0.1 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.2 | GO:0016503 | pheromone receptor activity(GO:0016503) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 47.6 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
2.6 | 48.6 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
2.4 | 60.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
2.3 | 34.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
2.3 | 100.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
2.0 | 48.9 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
2.0 | 27.5 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
2.0 | 62.6 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
1.9 | 15.4 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
1.7 | 1.7 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
1.5 | 61.9 | PID RAC1 PATHWAY | RAC1 signaling pathway |
1.5 | 18.4 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
1.5 | 13.7 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
1.5 | 46.8 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
1.5 | 20.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
1.5 | 43.0 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
1.4 | 36.1 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
1.4 | 5.8 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
1.4 | 5.8 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
1.4 | 17.0 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
1.4 | 59.4 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
1.4 | 1.4 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
1.3 | 132.6 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
1.3 | 1.3 | PID S1P S1P2 PATHWAY | S1P2 pathway |
1.3 | 26.4 | PID RAS PATHWAY | Regulation of Ras family activation |
1.3 | 7.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
1.3 | 27.6 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
1.2 | 3.7 | PID ALK2 PATHWAY | ALK2 signaling events |
1.2 | 50.7 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
1.2 | 16.7 | PID ALK1 PATHWAY | ALK1 signaling events |
1.1 | 18.0 | PID IL2 1PATHWAY | IL2-mediated signaling events |
1.1 | 12.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
1.1 | 7.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
1.1 | 40.6 | PID P53 REGULATION PATHWAY | p53 pathway |
1.1 | 9.6 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
1.1 | 17.0 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
1.1 | 1.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
1.1 | 2.1 | PID MYC PATHWAY | C-MYC pathway |
1.0 | 18.9 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
1.0 | 21.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
1.0 | 55.3 | PID CMYB PATHWAY | C-MYB transcription factor network |
1.0 | 10.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
1.0 | 18.5 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
1.0 | 8.0 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
1.0 | 7.0 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
1.0 | 5.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
1.0 | 11.7 | PID IFNG PATHWAY | IFN-gamma pathway |
1.0 | 15.5 | PID AURORA A PATHWAY | Aurora A signaling |
1.0 | 4.8 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.9 | 5.7 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.9 | 7.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.9 | 31.0 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.9 | 27.6 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.9 | 20.9 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.9 | 8.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.9 | 7.7 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.8 | 30.4 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.8 | 0.8 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.8 | 7.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.8 | 9.8 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.8 | 4.0 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.8 | 28.8 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.8 | 5.5 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.8 | 15.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.8 | 14.2 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.8 | 14.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.8 | 6.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.7 | 8.2 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.7 | 15.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.7 | 22.7 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.7 | 5.0 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.7 | 1.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.7 | 8.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.7 | 31.8 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.7 | 8.1 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.7 | 18.1 | PID NOTCH PATHWAY | Notch signaling pathway |
0.7 | 15.7 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.6 | 3.2 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.6 | 12.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.6 | 4.4 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.6 | 8.6 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.6 | 13.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.6 | 12.4 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.6 | 13.9 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.5 | 3.7 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.5 | 3.2 | PID ATR PATHWAY | ATR signaling pathway |
0.5 | 11.6 | PID PLK1 PATHWAY | PLK1 signaling events |
0.5 | 1.5 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.5 | 5.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.5 | 17.6 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.5 | 15.8 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.5 | 2.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.5 | 4.8 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.5 | 2.9 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.5 | 5.7 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.5 | 24.2 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.5 | 8.9 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.5 | 2.3 | PID BARD1 PATHWAY | BARD1 signaling events |
0.5 | 6.0 | NABA COLLAGENS | Genes encoding collagen proteins |
0.5 | 0.5 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.5 | 2.3 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.5 | 5.0 | ST ADRENERGIC | Adrenergic Pathway |
0.5 | 1.8 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.5 | 9.0 | PID P73PATHWAY | p73 transcription factor network |
0.5 | 3.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.5 | 2.7 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.4 | 1.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.4 | 2.6 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.4 | 5.9 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.4 | 7.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.4 | 8.0 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.4 | 6.6 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.4 | 50.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.4 | 2.6 | PID FGF PATHWAY | FGF signaling pathway |
0.4 | 0.7 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.4 | 4.6 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.3 | 0.7 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.3 | 3.7 | PID RHOA PATHWAY | RhoA signaling pathway |
0.3 | 1.0 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.3 | 3.0 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.3 | 5.4 | PID LKB1 PATHWAY | LKB1 signaling events |
0.3 | 1.7 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.3 | 4.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.3 | 3.9 | PID ARF 3PATHWAY | Arf1 pathway |
0.3 | 0.6 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.3 | 7.3 | PID AURORA B PATHWAY | Aurora B signaling |
0.3 | 0.9 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.3 | 0.6 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.3 | 0.9 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.3 | 0.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.3 | 2.4 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.3 | 0.5 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 3.9 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 2.9 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.2 | 1.7 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 1.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 1.0 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 3.6 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.2 | 2.6 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.2 | 1.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 1.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.2 | 3.3 | PID BMP PATHWAY | BMP receptor signaling |
0.2 | 1.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.2 | 0.8 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.2 | 2.3 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.2 | 0.4 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 1.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 0.2 | PID EPO PATHWAY | EPO signaling pathway |
0.2 | 1.4 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.2 | 3.0 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 1.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 25.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 16.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 0.3 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 17.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.3 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.2 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.1 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.5 | 48.5 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
3.1 | 12.4 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
3.0 | 3.0 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
2.8 | 22.0 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
2.7 | 27.3 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
2.5 | 63.0 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
2.4 | 35.7 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
2.3 | 18.7 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
2.2 | 6.6 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
2.1 | 21.2 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
1.9 | 17.2 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
1.9 | 31.7 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
1.8 | 18.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
1.8 | 3.7 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
1.8 | 85.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
1.7 | 27.8 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
1.7 | 8.7 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
1.7 | 13.7 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
1.6 | 1.6 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
1.6 | 29.1 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
1.6 | 39.4 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
1.6 | 42.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
1.6 | 1.6 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
1.5 | 3.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
1.5 | 46.1 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
1.5 | 1.5 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
1.5 | 26.0 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
1.5 | 7.6 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
1.5 | 13.5 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
1.5 | 17.9 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
1.5 | 2.9 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
1.4 | 20.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
1.4 | 27.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
1.4 | 7.1 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
1.4 | 34.1 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
1.4 | 12.5 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
1.4 | 8.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
1.4 | 13.6 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
1.3 | 29.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
1.3 | 19.6 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
1.3 | 58.4 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
1.3 | 21.8 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
1.3 | 3.8 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
1.3 | 29.0 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
1.2 | 2.5 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
1.2 | 8.6 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
1.2 | 7.3 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
1.2 | 4.8 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
1.2 | 32.3 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
1.2 | 16.6 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
1.2 | 11.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
1.1 | 3.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
1.1 | 5.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
1.1 | 26.4 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
1.1 | 11.9 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
1.1 | 23.9 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
1.1 | 17.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
1.1 | 9.7 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
1.1 | 24.8 | REACTOME G1 PHASE | Genes involved in G1 Phase |
1.1 | 12.7 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
1.0 | 7.3 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
1.0 | 14.4 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
1.0 | 1.0 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
1.0 | 5.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
1.0 | 3.0 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
1.0 | 27.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
1.0 | 2.9 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
1.0 | 7.8 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
1.0 | 3.8 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
1.0 | 10.5 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.9 | 26.6 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.9 | 1.9 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.9 | 13.3 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.9 | 14.1 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.9 | 9.3 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.9 | 14.8 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.9 | 5.5 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.9 | 11.0 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.9 | 6.3 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.9 | 13.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.9 | 3.6 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.9 | 16.0 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.9 | 10.5 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.9 | 7.9 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.9 | 7.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.9 | 2.6 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.9 | 2.6 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
0.9 | 19.8 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.9 | 13.7 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.9 | 3.4 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.8 | 2.5 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.8 | 8.4 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.8 | 6.7 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.8 | 5.0 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.8 | 38.9 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.8 | 5.8 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.8 | 3.3 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.8 | 10.6 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.8 | 22.0 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.8 | 9.0 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.8 | 2.4 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.8 | 8.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.8 | 10.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.8 | 12.8 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.8 | 4.0 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.8 | 3.2 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.8 | 1.6 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.8 | 59.1 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.8 | 15.7 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.8 | 7.8 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.8 | 10.0 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.8 | 12.9 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.8 | 11.3 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.7 | 6.7 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.7 | 80.5 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.7 | 13.4 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.7 | 1.5 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.7 | 8.8 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.7 | 14.6 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.7 | 5.8 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.7 | 10.1 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.7 | 19.9 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.7 | 23.1 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.7 | 2.0 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.7 | 11.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.7 | 3.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.7 | 0.7 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.7 | 2.6 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.6 | 3.8 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.6 | 57.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.6 | 8.1 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.6 | 6.8 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.6 | 1.2 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.6 | 18.2 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.6 | 2.4 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.6 | 3.6 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.6 | 10.8 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.6 | 19.7 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.6 | 1.8 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.6 | 0.6 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.6 | 12.4 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.6 | 1.8 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.6 | 1.2 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.6 | 6.5 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.6 | 8.6 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.6 | 7.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.6 | 5.1 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.6 | 10.2 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.6 | 9.6 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.6 | 10.1 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.6 | 32.7 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.6 | 0.6 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.6 | 1.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.6 | 14.9 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.6 | 0.6 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.5 | 1.6 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.5 | 12.0 | REACTOME PI3K EVENTS IN ERBB2 SIGNALING | Genes involved in PI3K events in ERBB2 signaling |
0.5 | 6.0 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.5 | 4.3 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.5 | 5.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.5 | 11.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.5 | 12.5 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.5 | 2.1 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.5 | 46.7 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.5 | 3.0 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.5 | 1.0 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.5 | 1.5 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.5 | 0.5 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.5 | 0.5 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.5 | 7.3 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.5 | 6.2 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.5 | 5.7 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.5 | 3.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.5 | 0.5 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.5 | 9.2 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.5 | 7.3 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.5 | 1.4 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.5 | 18.0 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.4 | 8.5 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.4 | 8.3 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.4 | 0.9 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.4 | 5.2 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.4 | 6.4 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.4 | 4.2 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.4 | 0.8 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.4 | 4.1 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.4 | 2.9 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.4 | 13.5 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.4 | 0.8 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.4 | 3.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.4 | 2.3 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.4 | 2.3 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.4 | 16.9 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.4 | 1.1 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.4 | 6.3 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.4 | 16.5 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.4 | 4.7 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.4 | 31.6 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.4 | 14.8 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.4 | 5.4 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.4 | 5.3 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.4 | 3.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.3 | 4.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.3 | 2.8 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 8.3 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.3 | 4.1 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.3 | 3.5 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.3 | 2.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.3 | 4.4 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.3 | 4.1 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.3 | 1.5 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.3 | 1.5 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.3 | 0.3 | REACTOME DOWNSTREAM SIGNALING OF ACTIVATED FGFR | Genes involved in Downstream signaling of activated FGFR |
0.3 | 1.2 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.3 | 3.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.3 | 0.3 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.3 | 1.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.3 | 4.1 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.3 | 4.6 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.3 | 3.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.3 | 1.9 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.3 | 4.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.3 | 1.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.3 | 39.1 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.3 | 12.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 4.0 | REACTOME PHOSPHOLIPID METABOLISM | Genes involved in Phospholipid metabolism |
0.2 | 1.6 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.2 | 1.1 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.2 | 12.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.2 | 2.8 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 3.5 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.2 | 4.3 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.2 | 3.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.2 | 0.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.2 | 0.9 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.2 | 1.4 | REACTOME OPSINS | Genes involved in Opsins |
0.2 | 0.7 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.2 | 1.2 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.2 | 3.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.2 | 4.4 | REACTOME TRANSLATION | Genes involved in Translation |
0.2 | 1.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.2 | 0.2 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.2 | 0.3 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.2 | 0.8 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 26.9 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.1 | 2.6 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.1 | 0.2 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.1 | 0.4 | REACTOME METABOLISM OF MRNA | Genes involved in Metabolism of mRNA |
0.1 | 0.4 | REACTOME HEMOSTASIS | Genes involved in Hemostasis |
0.1 | 1.0 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
0.1 | 4.4 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 4.0 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.1 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 2.9 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.4 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 0.2 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.1 | 1.3 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 0.6 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.1 | 0.8 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 0.1 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
0.1 | 6.4 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 0.9 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.1 | 5.1 | REACTOME METABOLISM OF CARBOHYDRATES | Genes involved in Metabolism of carbohydrates |
0.1 | 0.1 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.1 | 0.6 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.1 | 0.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 0.7 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.0 | 0.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.1 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
0.0 | 0.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.1 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 0.0 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 0.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |